#: :filename=share/databases/FNL/Nov2017_update/Thomas2015#:type=:double
#Transcription Factor (Associated Gene Name)	Target Gene (Associated Gene Name)	sentence	class	details	PMID
FOSB	CREM|CREM|SRF|SRF|SRF|SRF|YY1|CREB1|FOSB|CREM|MYB|MYB|FOSB|FOSB|FOSB|FOSB|JUN|GATA1|FOSB|JUN|TBPL1|FOSB|MAZ|FOSB|FOSB|AIRE|AIRE|PSORS1C2|FOSB|FOSB|CYP27B1|CYP27B1|YY1|MYCN|DDIT3|HNF4A|EN2|YBX1	We conclude that CREM represses the expression of c-fos and limits the activity of the enhancer AP-1.|We conclude that CREM represses the expression of c-fos and limits the activity of the enhancer AP-1.|These findings imply possible roles for SRF phosphorylation in the regulation of c-fos transcription|In the case of the human serum response factor (SRF)|We conclude that band I in neonates represents a SRE-binding factor that is distinct from the SRF|A short DNA sequence element|Yin-Yang-1 (YY1) regulates the transcription of many genes|Cells with anchored PKAII exhibited a threefold higher level of nuclear catalytic subunit content and 4-10-fold greater increments in phosphorylation of a regulatory serine residue in cAMP response element binding protein (CREB) and in phosphoCREB-stimulated transcription of the c-fos gene.|The ability of ligands to modulate transcription of AP-1- or Sp1-containing promoters was dependent on cell context|Inducible cAMP early repressor splice variants ICER I and IIgamma both repress transcription of c-fos and chromogranin A.|A correlation was evident between the potency of these compounds as inducers of differentiation demonstrated by nonspecific esterase activity|In most cell types|The increase in AP-1-binding activity was accompanied by the marked stimulation of the transcription of c-fos but not that of c-jun.|A 23-base pair DNA element containing the overlapping glucocorticoid-responsive element and AP-1 sites can be positively regulated by glucocorticoid receptor in the absence of c-jun/c-fos products.|This AP-1-like element|It is concluded that a) the inhibition of transforming growth factor beta autostimulation by HDL3 plus LDL may involve reduced AP-1 activity via a reduction of c-fos expression by the lipoprotein combination and b) the ratio HDL3:LDL might influence the pathogenesis of arteriosclerosis via growth-related events in the arterial wall|Although recent reports have shown that fos protein binds to AP1-binding sites through an interaction with AP1 protein and have raised the speculation that fos protein may negatively regulate expression of the c-fos gene via this interaction|Thus|Since FOS and JUN proteins form a transacting activator (AP-1) for expression of collagenase and stromelysin genes|Since FOS and JUN proteins form a transacting activator (AP-1) for expression of collagenase and stromelysin genes|TATA-binding protein (TBP)-like factor (TLF) is a functional regulator of transcription: reciprocal regulation of the neurofibromatosis type 1 and c-fos genes by TLF/TRF2 and TBP.|In this study|We present evidence that knockdown of SAF-1 by small interfering RNAs inhibits AP-1-mediated increase of human MMP-1 expression.|Moreover|Interestingly|Because we recently found functional HSEs in the human and rodent c-fos promoters|In this study|AP-1 is the cis element mediating the transcriptional activation of SPR1 by PMA|AP-1 is the cis element mediating the transcriptional activation of SPR1 by PMA|Mutation of the AP-1 site abolishes the induction of SPR1 expression by PMA.|Both the p38 and JNK MAPK pathways and the downstream transcription factor c-Jun/AP-1 are required for the VDR stimulation|Both the p38 and JNK MAPK pathways and the downstream transcription factor c-Jun/AP-1 are required for the VDR stimulation|Furthermore|We examined the genomic amplification of N-myc in 26 specimens of neuroblastomas and further analyzed 22 of the 26 cases for expression of N-myc|Unlike GADD45|DN-MKL1 reduced the late stage of serum induction of endogenous c-fos expression|Besides the ontogenesis of the cerebellar cortex in man|YB-1 represses tumor promoter-induced MMP-13 promoter transactivation at the AP-1 site.	TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|FP|FP|NN|NN|NN|NN|NN|NN|NN|NN|NN|NN|NN|TP|FP|FP|FP|TP|TP|TP|TP|TP|TP|FP|FP|FP|FP|FP	database|database|database|database|database|database|database|database|database|database|general or irrelevant information|general or irrelevant information|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|potential direct influence on expression|negative statement|general or irrelevant information|general or irrelevant information|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information	15322221|1547771|1652755|3119326|8266081|8909793|9734357|17308128|2463066|3137398|2498163|8985358|17235455|17348214|8920856|11859076|11026560.0|20430007|8541224|8723988|12944485|19795350||||||||||||||||
FOXM1	TTF1|FOXM1|FOXM1|FOXM1|GLI1	Modulation of TTF-1 gene expression by members of the HNF-3/forkhead family members may provide a mechanism by which distinct HNF-3/forkhead family members influence respiratory epithelial cell gene expression and cell differentiation|Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer.|These results suggest that gefitinib represses FOXM1 expression via FOXO3a in breast cancer.|In this study|Expression of transcription levels of GLI1 and FOXM1 correlated with SHh expression (SHh vs GLI1	TP|TP|TP|TP|FP	database|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|general or irrelevant information	8668179|19276163|20208560||
YBX1	ARHGAP24|ARHGAP24|MYC|YBX1	Our data suggest that p73 stimulates the transcription of the YB-1 promoter by enhancing recruitment of the c-Myc-Max complex to the E-box|p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression.|p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression.|Furthermore	TP|TP|TP|TP	database|database|database|binding to regulatory DNA-region/potential direct influence on expression	12080043|14738225||20004191
MYC	MYC|MYC|MYC|MYC|CNBP|MYC|MYC|MYC|MYC|MYC|MYC|MYC|HIF1A|KLF2|MYC|KLF2|MYC|RUNX3|RUNX3|MYC|MYC|MYC|HIF1A|FOS|JUN|TCF7L2|MXI1|SETD2|MYC|MAD1L1|KLF5|KLF5|KLF5|KLF5|ID2|MYC|MYB|MYC|E2F5	Here we demonstrate that the human p53 promoter is transactivated by high c-Myc expression and repressed by high Max expression.|Taken together|Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.|Together|Several reports have demonstrated that CNBP enhances the transcription of c-Myc in vitro and in vivo; however|Chromatin immunoprecipitation assay and RNA interference studies with cells deficient in p53 and p21 show that ascofuranone induces p21(WAF1/CIP1) expression and subsequent G(1) arrest through the release of p21(WAF1/CIP1) promoter from c-Myc-mediated transcriptional repression|Further|Their function is mediated by switches in the dimerization partners; c-Myc does not homodimerize in vivo but competes with Mad|RESULTS: We found that c-Myc directly bound to the N-terminal region of origin recognition complex-1 (ORC1)|METHODS AND RESULTS: OxLDL enhanced c-Myc/Max expression and transcription by cotransfection assay and the nuclear activities of E2F and activator protein-2 by binding shift and supershift in coronary SMCs.|On the other hand|On the other hand|HIF-1alpha action via the HIF-1alpha-c-Myc axis is independent of its DNA-binding and transactivation domains; instead it requires the PAS-B domain to displace the transcription activator c-Myc from the target gene promoter for gene repression.|Forced expression of LKLF was associated with markedly decreased c-Myc expression.|Forced expression of LKLF was associated with markedly decreased c-Myc expression.|In addition|c-Myc oncogene was found to be downregulated by BMP and/or RUNX3.|We show that upregulation of RUNX3 by BMP reduces c-Myc expression.|Evidence is presented suggesting that RUNX3 downregulates c-Myc expression by two parallel pathways-directly at the transcriptional level and through attenuation of beta-catenin/TCFs|The recent discovery of Max|AMY-1 by itself did not recognize the E-box element|This result is in contrast with the inhibition of erythroid differentiation of K562 exerted by c-Myc|Under arginine depletion conditions|These results raise the possibility that FOS and JUN participate in the regulation of MYC|These results raise the possibility that FOS and JUN participate in the regulation of MYC|These findings suggest that some splicing forms of TCF7L2 may be functionally important for regulation of MYC expression in colon tissue but this regulation is not directly dependent on rs6983267.|MXI1 encodes a basic-helix-loop-helix protein that suppresses the transcriptional activity of the MYC oncoprotein by competing for the common dimerization partner|As hypoxia signals a cellular deprivation state|MAX dimerization protein 1 (MAD1) is a transcription suppressor that antagonizes MYC-mediated transcription activation|MAX dimerization protein 1 (MAD1) is a transcription suppressor that antagonizes MYC-mediated transcription activation|In this study we investigated whether KLF5 directly regulates MYC transcription in epithelial cells in the context of TGFbeta.|Knockdown of KLF5 significantly reduced MYC expression in the HaCaT epidermal epithelial cells.|Opposing effects of KLF5 on the transcription of MYC in epithelial proliferation in the context of transforming growth factor beta.|When TGFbeta was applied|Recently|We explored the relationship between activated Wnt signaling and MYB in regulating MYC and found activated beta-catenin in combination with MYB induces robust upregulation of MYC promoter activity|These data highlight a cooperative function for MYB in the context of activated Wnt signaling and provide a molecular basis for the expression of MYC in CRC.|AMY-1 by itself did not recognize the E-box element|This suggests that E2F5 behaves like a MYC-type cooperating oncogene in functional assays	TP|TP|TP|TP|TP|TP|TP|NN|NN|NN|NN|NN|NN|TP|TP|TP|TP|TP|TP|FP|FP|FP|FP|TP|TP|TP|NN|NN|NN|NN|TP|TP|TP|TP|TP|TP|FP|FP|FP	database|database|database|database|database|database|binding to regulatory DNA-region|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|database|database|database|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information	7969121|12565816|15208653|15647429|7577944|8417337|18722373|10672043|15489884|1323849|11422041|||||||||||||2498162|19895682|19696787|17785433|19526459|19684017|12545167|19609274|9797456|10738311||||||
LEF1	HNF4A|MITF|PITX2	beta-catenin/TCF complexes can activate the promoter for full-length LEF1|This study therefore suggests that the MITF/TFE3 family is a new class of nuclear modulators for LEF-1|beta-catenin directly interacts with PITX2 to synergistically regulate LEF-1 expression.	TP|TP|TP	database|database|potential direct influence on expression	11326276|12032083|15728254
RARA	CYP27B1|CYP27B1|JUN|JUN|JUN|JUN|RARA|CREB1	Incubation with vitamin D markedly reduced the response to RA caused by transcriptional interference of the vitamin D receptor (VDR) on the RARE.|In combination with all-trans-retinoic acid|AP1 transrepression by retinoids was RAR and ligand dependent|Therefore|Retinoids|Some of the therapeutic actions of retinoids can be ascribed to retinoic acid receptor (RAR)-mediated antagonism of AP1-dependent gene expression.|To gain insight into the molecular mechanism of RAR-AP1 interaction|Interestingly	TP|NN|NN|TP|TP|TP|TP|FP	database|cooperation/competition in transcription|cooperation/competition in transcription|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information	10342883|12052862|10329471|19416972||||
MYB	JUN|WT1|IRF1|MYB|E2F1|PAX6|MYC|MYB|NFIB|MYB	Because T-lymphocytes induced to proliferate express c-jun and junD before c-myb|We conclude that WT1 is a negative regulator of c-myb expression in both T and B cell lines|Together|Together|Taken together|C-Myb acts as transcriptional activator of the quail PAX6 (PAX-QNR) promoter through two different mechanisms.|We explored the relationship between activated Wnt signaling and MYB in regulating MYC and found activated beta-catenin in combination with MYB induces robust upregulation of MYC promoter activity|These data highlight a cooperative function for MYB in the context of activated Wnt signaling and provide a molecular basis for the expression of MYC in CRC.|Our data indicate that the MYB-NFIB fusion is a hallmark of ACC and that deregulation of the expression of MYB and its target genes is a key oncogenic event in the pathogenesis of ACC.|Our findings also suggest that the gain-of-function activity resulting from the MYB-NFIB fusion is a candidate therapeutic target.	TP|TP|TP|TP|TP|TP|TP|FP|FP|FP	database|database|database|database|database|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|incorrectly recognized gene name or identifier|incorrectly recognized gene name or identifier	1527086|10739671|15867358|7838532|2694722||19609274|19841262||
NR3C1	JUN	While the GCR is a potent inhibitor of AP-1 activity (Jun/Fos)	TP	potential direct influence on expression	
NR0B1	NR5A1|NR5A1|NR5A1|NR0B1|NR5A1|NR5A1|NR0B1|NR0B1|NR0B1|NR0B1|NR5A1|NR5A1|PBX1	This suggests that SF-1 may directly regulate the expression of DAX-1 and that these two transcription factors may be components of a cascade required for development of steroidogenic tissues.|With respect to implication of Ad4BP/SF-1 in the transcriptional regulation of the DAX-1 gene|DAX-1 is a repressor of StAR gene expression|DAX-1 is a repressor of StAR gene expression|Mutation of the SF-1-binding sites within the hACTH-R promoter resulted in reduced or abolished DAX-1 inhibition|When cotransfected with 1550 bp of the DAX1 promoter|DAX1 gene expression upregulated by steroidogenic factor 1 in an adrenocortical carcinoma cell line.|When cotransfected with 1550 bp of the DAX1 promoter|Functional analysis showed that DAX1 acts as a repressor against SF1 through direct interaction between the repeated sequences at the N-terminus of DAX1 and a ligand-binding domain of SF1.|DAX1 opposed SF1-activated transcription of many genes and abolished the GATA-6/SF1 ability to increase reporter activity.|Transfection of HEK293 cells with both GATA-6 and SF1 significantly increased transcriptional activation of all reporter constructs above the effect of GATA-6 or SF1 alone.|DAX1 opposed SF1-activated transcription of many genes and abolished the GATA-6/SF1 ability to increase reporter activity.|Both genes are activated by SF-1 in a dose-dependent manner in NCI-H295R cells	TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|NN|FP|TP	database|database|database|database|database|database|database|database|database|database|cooperation/competition in transcription|general or irrelevant information|potential direct influence on expression	7677767|10446902|11297612|15879363||9232190|11990799|12959982|18984668||||
TAL1	GATA1|GATA3|GATA1|TCF12|TCF12|NFKB1|NFKB1	Altogether our results strongly suggest that GATA-1 modulates the transcription of tal-1 during the differentiation of the erythroid|In this context|Finally|TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB.|These data demonstrate that tal1/scl induces leukemia by repressing E47/HEB and suggest that HDAC inhibitors may prove efficacious in T-ALL patients who express TAL1/SCL|Moreover|When TAL1 expression is reduced in CEM T leukemia cells	TP|TP|TP|TP|TP|TP|TP	database|database|database|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	7678994|9020185|20566737|15193261|16778171||
E2F1	MAZ|MAZ|HOXB7|FOSB|HIF1A|HIF1A|NFYA|NFYA|MYC|MYC|E2F1|E2F1|MXI1|POLD1|POLD1|MYC|MYC|ARHGAP24|ARHGAP24|ARHGAP24|ARHGAP24|E2F1|E2F1|E2F1|HNF4A|TBP|YY1|ETV4|HIF1A|TBP|NCOA3|KLF4|KLF15|TFCP2|ZNF148|KLF6|KLF9|KLF9|TAF1|KLF11|TBP|E2F1|ARHGAP24|ARHGAP24|TP53BP1|TP53BP1|ARHGAP24|E2F1|E2F1|ARHGAP24|ARHGAP24|TP53BP1|TP53BP1|ARHGAP24|ARHGAP24|ARHGAP24|FBXW11|FBXW11|MYC|MYC|ARHGAP24|ARHGAP24|ARHGAP24|LEF1|E2F1|E2F1|ETV4	Both Sp1 and MAZ inhibited the expression of the gene for MAZ|Our results suggest|HOXB7 expression is regulated by the transcription factors NF-Y|The ability of ligands to modulate transcription of AP-1- or Sp1-containing promoters was dependent on cell context|HIF-1alpha displaces the transcriptional activator Myc from Sp1 binding to repress MutSalpha expression in a p53-dependent manner; Sp1 serves as a molecular switch by recruiting HIF-1alpha to the gene promoter under hypoxia.|HIF-1alpha displaces the transcriptional activator Myc from Sp1 binding to repress MutSalpha expression in a p53-dependent manner; Sp1 serves as a molecular switch by recruiting HIF-1alpha to the gene promoter under hypoxia.|Overexpression of NF-YA had a synergistic effect on Sp1 overexpression and an additive effect on Sp3 overexpression.|Overexpression of NF-YA had a synergistic effect on Sp1 overexpression and an additive effect on Sp3 overexpression.|Regulation of MYC promoter activity critically depends on the presence of a binding site for transcription factor E2F.|Using CAT reporter co-transfection assays we show here that transcription from the MYC P2 promoter is induced efficiently by E2F-1|Thus|Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions.|Expression of MXI1|Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.|When ectopic wild-type p53 expression was induced to a physiologically relevant level in "tet-off" cultured cells in which p53 expression was tightly regulated by tetracycline|Furthermore|Restoration of c-Myc in non-adherent cells induces the expression of E2F-1|Expression of p73beta was mediated by E2F-1|Induction of p73beta by a naphthoquinone analog is mediated by E2F-1 and triggers apoptosis in HeLa cells.|The p73 protein activates the transcription of genes downstream of p53 and induces apoptosis when overexpressed in several cell lines|The p73 protein activates the transcription of genes downstream of p53 and induces apoptosis when overexpressed in several cell lines|Ectopic expression of E2F-1 repressed hTERT promoter activity by inhibiting Sp1 activation of the hTERT promoter.|Cotransfection assays showed that activation of dhfr transcription by expression of E2F1/DP1 requires the reiterated Sp1 elements|Cotransfection of the luciferase reporter with either Sp1- or E2F1-expression plasmid further verified the role of Sp1 as a transcriptional activator and E2F1 as a transcriptional repressor in the human MCAK promoter|Overexpression of HNF4alpha led to a dramatic repression of the promoter activity and|First|In contrast|Biologically|Finally|Functional analysis of partial TFIID complexes formed in vivo indicated that hTAF(II)130 was required for transcriptional activation by Sp1 in vitro.|Sp1|Enforced KLF4 expression repressed Sp1 expression at the promoter activity|Using Drosophila SL2 cells|Thus|Immunocytochemical studies confirmed that ZBP-89 expression is elevated in neoplastic tissue and chronic gastritis|We also show that GBF belongs to a subgroup of KrAzppel-type zinc fingers distinct from Sp1.|In the present study|Thus the identification of this protein expands the repertoire of BTEB-like members of the Sp1-like protein family involved in transcriptional repression.|Here we provide evidence that TAF1 serves two independent functions|AIMS/HYPOTHESIS: The KrAzppel-like factor 11 (KLF11; TIEG2)|TBP-associated factor 4 (TAF4)|Here we provide evidence that E2F1 directly activates transcription of TP73|Disruption of p73 function by a tumour-derived p53 mutant reduced E2F1-mediated apoptosis.|Disruption of p73 function by a tumour-derived p53 mutant reduced E2F1-mediated apoptosis.|Molecular analysis of the TP73 gene on 1p36 and the TP53 gene revealed a deletion of one-allele in TP73 with partial demethylation of another allele in the initial clone of YSK|Although the TP53 gene is frequently mutated in human cancers|The p73alpha protein is a functional homolog of the p53 tumor suppressor.|DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.|Furthermore|DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.|DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.|Unlike in TP53 gene|Unlike in TP53 gene|Our results suggest that regulation of p73 expression is primarily mediated through binding of E2F1 to target sites at -155 and -132.|Namely|Namely|Namely|Namely|c-Myc-regulated microRNAs modulate E2F1 expression.|These findings expand the known classes of transcripts within the c-Myc target gene network|We show that DeltaNp73 antagonizes the repressive effect of the proapoptotic p53 family members on hTERT expression and|We show that forced expression of p73 or activation of endogenous p73 by E2F1 results in the downregulation of telomerase activity.|The results presented here suggested the cooperative transcriptional regulation of p73 by YY1 and E2F1|LEF-1 activates the transcription of E2F1.|DNA damage by etoposide causes E2F1-dependent induction of E1AF expression at transcriptional level.|Here|Furthermore	TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|NN|NN|NN|TP|TP|TP|TP|TP|FP|FP|FP|FP|FP|FP|FP|FP|TP|TP|TP|TP|TP|TP|p73 is a member of the p53 family often overexpressed in human cancer.|TP|p73 is a member of the p53 family often overexpressed in human cancer.|p73 is a member of the p53 family often overexpressed in human cancer.|TP|TP|TP|TP|TP|FP|FP|TP|TP|TP|TP|TP|TP|TP|TP|FP	database|database|database|database|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|database|database|database|database|database|database|database|database|binding to regulatory DNA-region/potential direct influence on expression|database|database|database|database|database|database|database|database|database|database|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|database|database|database|database|database|database|TP|database|TP|TP|database|database|database|database|potential direct influence on expression|incorrectly recognized gene name or identifier|incorrectly recognized gene name or identifier|database|database|database|database|database|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|general or irrelevant information	15780936|16024108|9224612|9610763|10984499|11337507|12972613|15024015|19401466|19912441|9199306|9748148|9769946|15004518|18338249|17490644|18640248|10425220|10896937|15517862|16714330|16916939|20160399|12036432|12569092|19035040||||||||||||||||11101847|11550287|12716888|18348649|11988839|12789260|15944709|16205639|17784791|17980704|18345030|19603422|19629135|19806017|15313206|17980157|18687701|16037820|15190206|12909334|20338640|||||
MAZ	MAZ|MAZ|PPARG	Both Sp1 and MAZ inhibited the expression of the gene for MAZ|Our results suggest|Myc-associated zinc finger protein (MAZ) was identified as a transcriptional mediator of PPARgamma1 expression in these cells.	TP|TP|TP	database|database|potential direct influence on expression	19061500||
WT1	GATA1|PAX2|PAX2|PAX2|WT1|GATA1|WT1|WT1|SRY|SRY|WT1|SRY|GATA1|GATA1|PAX2|PAX8|WT1|WT1|PAX2|WT1|WT1|WT1|ARHGAP24|MYCN|IRF8|IRF8|WT1|WT1|CTCF	Previous studies of WT1 gene regulation showed that GATA-1 may regulate WT1 expression.|The overlap of PAX2 and WT1 expression in fetal kidney prompted us to determine whether PAX2 regulates the WT1 gene.|These findings suggest that PAX2 is a tissue-specific modulator of WT1 expression|We suggest that persistent expression of PAX2 is likely to result from the loss of WT1 dependent transcriptional repression and may participate in the pathological mechanisms leading to glomerular dysfunction.|One target gene of WT1 is PAX2|Using a sensitive|WT1 transcription is regulated in erythroid and myeloid lineages by the transcription factor GATA-1.|These observations|In this study we investigated the regulation of the sex determination gene SRY by WT1.|The human sex-determining gene SRY is a direct target of WT1.|Wildtype WT1 is recruited to SRY-binding sites in an SRY-dependent manner|Transcriptional activity of testis-determining factor SRY is modulated by the Wilms' tumor 1 gene product|In conclusion|PAX2|PAX2|PAX2|Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias.|Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias.|Additional analyses indicated that PAX2 repressor WT1 and cancer-linked hypomethylation are not important for transcriptional regulation of PAX2 in ccRCC.|Additional analyses indicated that PAX2 repressor WT1 and cancer-linked hypomethylation are not important for transcriptional regulation of PAX2 in ccRCC.|Several proteins bind to and alter the transcription regulatory properties of the WT1 proteins|Similarly|Similarly|Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.|A reporter construct with the IRF8 promoter was repressed by WT1|In this study|Interestingly|Upon overexpression in CD34+ progenitors|A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS and exhibits sequential epigenetic defects during Wilms' tumourigenesis.	TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|NN|TP|TP|TP|TP|TP|TP|TP|FP	database|database|database|database|database|database|database|database|database|database|database|database|database|database|database|database|database|database|database|database|cooperation/competition in transcription|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|incorrectly recognized gene name or identifier	8683991|9178767|9916932|10360378|11278460|12970737|14531904.0|19401348|15752709|8058069|10744705|7585606|9531608|10470095|11050081|12802290|15286719|17634147|20237505|17210670|||||||||
NR5A1	NR5A1|NR0B1|NR0B1|NR0B1|NR0B1|NR5A1|NR5A1|PBX1|NR5A1|NR0B1|NR0B1|NR0B1|NR0B1|NR0B1|NR0B1|WT1|NR0B1	When cotransfected with 1550 bp of the DAX1 promoter|DAX1 gene expression upregulated by steroidogenic factor 1 in an adrenocortical carcinoma cell line.|When cotransfected with 1550 bp of the DAX1 promoter|Functional analysis showed that DAX1 acts as a repressor against SF1 through direct interaction between the repeated sequences at the N-terminus of DAX1 and a ligand-binding domain of SF1.|DAX1 opposed SF1-activated transcription of many genes and abolished the GATA-6/SF1 ability to increase reporter activity.|Transfection of HEK293 cells with both GATA-6 and SF1 significantly increased transcriptional activation of all reporter constructs above the effect of GATA-6 or SF1 alone.|DAX1 opposed SF1-activated transcription of many genes and abolished the GATA-6/SF1 ability to increase reporter activity.|Both genes are activated by SF-1 in a dose-dependent manner in NCI-H295R cells|DAX-1 is a repressor of StAR gene expression|DAX-1 is a repressor of StAR gene expression|Another orphan receptor|COUP-TF and DAX-1 have been shown to negatively regulate the transcriptional activity of SF-1|In contrast|Nuclear receptors in the pathophysiology of endocrine tumors|WT1 and DAX-1 regulate SF-1-mediated human P450arom gene expression in gonadal cells.|WT1 and DAX-1 regulate SF-1-mediated human P450arom gene expression in gonadal cells.|We found that	TP|TP|TP|TP|TP|NN|FP|TP|TP|TP|TP|TP|TP|Nuclear orphan receptors COUP-TF and DAX-1 negatively regulate the transcriptional activity of SF-1|TP|TP|TP	database|database|database|database|database|cooperation/competition in transcription|general or irrelevant information|potential direct influence on expression|database|database|database|database|database|TP|database|potential direct influence on expression|database	9232190|11990799|12959982|18984668|||||11297612|11196414|11592817|11857908|14580722|17646707|||
MITF	PAX3|PAX3|SOX10|SOX10	These results provide evidence that PAX3 directly regulates MITF and suggest that the failure of this regulation due to PAX3 mutations causes the auditory-pigmentary symptoms in at least some individuals with WS1|By analyzing the genes for Waardenburg syndrome|Finally|Finally	TP|TP|TP|TP	database|database|database|database	9500554|10536986||
FOXD1	FOXD1|FOXD1|RUNX1|RUNX1|SLC9A3R2|HOXA10	In this paper we show that the kidney-expressed winged helix transcription factor FREAC-4 is regulated by Ets-1|The kidney-expressed winged helix transcription factor FREAC-4 is regulated by Ets-1.|Chromatin immunoprecipitation assays revealed that RUNX1 constitutively occupies the CD6 promoter in vivo|Chromatin immunoprecipitation assays revealed that RUNX1 constitutively occupies the CD6 promoter in vivo|Induced expression of Snail and SIP1 resulted in the increased expression of Ets-1 and DNA-binding activities of nuclear proteins to the Ets-1-binding site and strong Ets-1 expression was detected in highly invasive SCC cells.|Mutation of the GATA-1 and the Ets-1 motifs amplified the expression of HOXA10 in HEL and K562 cells	TP|TP|NN|FP|TP|TP	database|database|cooperation/competition in transcription|general or irrelevant information|potential direct influence on expression|potential direct influence on expression	9566892|19446338|17688409|17656364|20574810|11229456
ARHGAP24	ARHGAP24|TP63|E2F1|E2F1|ARHGAP24|ARHGAP24|ARHGAP24|MYC|ARHGAP24|ARHGAP24|ARHGAP24|ARHGAP24|ARHGAP24|ARHGAP24|E2F1|E2F1|ARHGAP24|ARHGAP24|E2F1|ARHGAP24|E2F1|ARHGAP24|TP63|NFKB1|ARHGAP24|ARHGAP24|E2F1|E2F1|E2F1|E2F1|E2F1|E2F1|ARHGAP24|TP53BP1|ARHGAP24|ARHGAP24|ARHGAP24|WT1|WT1|ARHGAP24|HSF1|MYCN|MYCN|CYP27B1|CYP27B1|MYCN|MYCN|ATF3|TP63	Thus|However|Here we show that E2F-1 induces the transcription of the p53 homologue p73.|Here we show that E2F-1 induces the transcription of the p53 homologue p73.|p73 is a member of the p53 family.|p73 is transcriptionally regulated by DNA damage|Taken together|More importantly|Thus|We show here that the expression of p73 Delta N is induced by p53 on the mRNA and protein level.|Ectopic overexpression of RACK1 in SAOS-2 cells reduced the p73alpha-mediated transcription from the p53/p73-responsive promoters|The fact that an ectopic expression of p73alphaR292H leads to both accumulation of p53 and stimulation of p53 target gene expression strongly suggests that p73alpha is able to induce activation of p53.|Using the adenoviral system|We thus conclude that p73alpha protein was able to both stabilize and activate wt-p53 protein|DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.|Furthermore|DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.|DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.|These pathways are related|The p16INK4a gene is involved in regulation of the G1/S transition|We demonstrate as well that E2F1 directs p73 expression in the presence and absence of DNA damage.|TA-p73/p63 demonstrate p53-like properties including gene transactivation and cell death promotion|TA-p73/p63 demonstrate p53-like properties including gene transactivation and cell death promotion|Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells.|Using p53 null cell lines|Some of the compounds activate a p53 response by increasing p73 expression|E2F-1 acts as a transcriptional regulator for p73.|Additionally|Immunoprecipitation experiments demonstrated that E2F1 forms a complex with p73 and inhibits the transcriptional activity of p73.|In this study|It has been shown that E2F1 acts as a transcriptional activator for p73.|Taken together|Chromatin immunoprecipitation showed that cisplatin removed DeltaNp73 from the PDGFRB promoter and recruited p53 and p73|Unlike the TP53 gene|Overall|Transcriptional regulation of the p73 gene|Overall|Several proteins bind to and alter the transcription regulatory properties of the WT1 proteins|Similarly|Similarly|Regulation of HSF1-responsive gene expression by N-terminal truncated form of p73alpha.|Our data suggest that the N-myc gene modulates expression of p73|N-myc modulates expression of p73 in neuroblastoma.|In conclusion|In conclusion|Herein|p73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells.|In contrast|Here we demonstrated that the p53 family member p63 controls a pathway for p73-dependent cisplatin sensitivity specific to these "triple-negative" tumors.	TP|TP|TP|TP|TP|TP|TP|NN|TP|TP|TP|TP|TP|TP|p73 is a member of the p53 family often overexpressed in human cancer.|TP|p73 is a member of the p53 family often overexpressed in human cancer.|p73 is a member of the p53 family often overexpressed in human cancer.|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|NN|TP|TP|NN|TP|FP|TP|TP|TP|TP|FP|FP	database|database|database|potential direct influence on expression|database|database|database|cooperation/competition in transcription|database|database|database|database|database|database|TP|database|TP|TP|database|database|database|database|database|database|database|database|database|database|database|database|database|database|database|database|database|database|binding to regulatory DNA-region/potential direct influence on expression|cooperation/competition in transcription|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|cooperation/competition in transcription|potential direct influence on expression|general or irrelevant information|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|incorrectly recognized gene name or identifier|general or irrelevant information	10469295|11238924|11909952.0|12101410|12917626|12934105|14602923|15849742|16430884|16835297|19067706|19952113|20026309|20231765|17822668|10744705|15081420|12192602|18583365|20528922|16738062||||||||||||||||||||||||||||
PAX2	PAX2|WT1|GATA1|GATA1|PAX2|PAX8|WT1|WT1|PAX2|WT1|STAT3	We suggest that persistent expression of PAX2 is likely to result from the loss of WT1 dependent transcriptional repression and may participate in the pathological mechanisms leading to glomerular dysfunction.|One target gene of WT1 is PAX2|In conclusion|PAX2|PAX2|PAX2|Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias.|Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias.|Additional analyses indicated that PAX2 repressor WT1 and cancer-linked hypomethylation are not important for transcriptional regulation of PAX2 in ccRCC.|Additional analyses indicated that PAX2 repressor WT1 and cancer-linked hypomethylation are not important for transcriptional regulation of PAX2 in ccRCC.|Moreover	TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|NN	database|database|database|database|database|database|database|database|database|database|indirect interaction	9916932|14531904.0|19401348|19118900|20597068|19517575|||||
GATA1	GATA1|WT1|SCLY|MECOM|RUNX1|JUN|RUNX1|GATA1|GATA1|GATA1|ARHGAP24	Using a sensitive|WT1 transcription is regulated in erythroid and myeloid lineages by the transcription factor GATA-1.|SCL gene expression was usually accompanied by GATA-1 expression and was preferentially detected in patients with leukemia exhibiting megakaryocytic or erythrocytic phenotypes|In addition|By contrast|Mutagenesis of c-Jun suggested that its repression of GATA-1 occurs through a transcriptional mechanism involving activation of downstream genes.|In this pathway|These effects were dependent on GATA-1-mediated repression of the c-myc (Myc) proto-oncogene.|These effects were dependent on GATA-1-mediated repression of the c-myc (Myc) proto-oncogene.|Whereas Gata2 is preferentially transcribed early in hematopoiesis|Furthermore	TP|TP|TP|NN|NN|FP|NN|TP|TP|TP|FP	database|database|database|cooperation/competition in transcription|cooperation/competition in transcription|general or irrelevant information|cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|general or irrelevant information	10360378|7579412|16177182|15314183|12832487|18195733|17420275|19212333|19279013||19509292
PPARG	SREBF2|PPARG|NR0B2|STAT3|STAT5A|KLF5|PPARG|PPARG|GPA33|KLF4|CDX2|KLF5|FOXA1|IRF1|PPARA|PPARG|PPARA|PPARA|IRF1|IRF1|IRF1|PPARA|PPARA|PPARA|PPARA|PPARA|CYP27B1|PPARA|CYP27B1|NR4A3|PPARG	The related transcription factor SREBP-2 likewise induced PPARgamma expression.|We investigated whether PPARgamma expression is dependent on the activity of adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1 (ADD-1/SREBP-1)|Herein|Interestingly|CONCLUSIONS: Reduced activation of colonic STAT5 and expression of PPARgamma may contribute to persistent mucosal inflammation in colitis.|KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.|These results suggest that PPARgamma in a ligand-dependent but DNA binding-independent manner inhibits Pax6 transcriptional activity|Activation of PPARdelta by long chain fatty acids impairs the expression of the determination factor MyoD1 and alpha-actin|This indicates that PPARgamma activation induces KLF4 expression|We also demonstrate that PPARgamma activation leads to increased (p21WAF1/Cip1 and keratin 19) or decreased (cyclin D1) expression of known KLF4 targets|CDXl|CDXl|FOXA1 and IRF-1 intermediary transcriptional regulators of PPARgamma-induced urothelial cytodifferentiation.|FOXA1 and IRF-1 intermediary transcriptional regulators of PPARgamma-induced urothelial cytodifferentiation.|Therefore|Therefore|Troglitazone and pioglitazone|In contrast|In contrast|METHODS AND RESULTS: Using Northern and Western blot analyses|PPARgamma-induced IRF-1 expression was abrogated by pretreatment with the PPARgamma antagonist GW9662.|Enhanced PPAR type alpha expression protects against cardiovascular disorders though the role of enhanced PPARgamma expression seems less favourable.|Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.|The aim was to study the effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue.|Whether other PPAR types can be found in human islets|After treatment with corresponding ligands|After treatment with corresponding ligands|In contrast|The strongest expression was found for the VDR|The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.|Western blot or immunohistochemical analyses confirm that PPARG and NDRG2 are expressed in tumours positive for EWSR1/NR4A3.	TP|TP|TP|NN|NN|NN|TP|TP|TP|TP|FP|FP|NN|NN|TP|FP|TP|TP|TP|TP|TP|FP|FP|FP|FP|FP|FP|FP|FP|TP|TP	database|database|database|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|general or irrelevant information|general or irrelevant information|indirect interaction|indirect interaction|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	10409739|15711576|14975242|16777921|18774944|11707457|12878168|18688264|11172467|11443177|14656743|17513608|10408502|12613669|14625208|19667161||||||||||||||18855877|
GLI3	GLI1|FOXM1|NR0B2|NR0B2|TCF7L2|TCF7L2	Much attention has been devoted to the expression pattern of GLI genes; GLI1 is induced by Shh|Expression of the Shh target glioma transcription factor-1 (Gli1) in primary keratinocytes and other cell lines caused a significant elevation of FOXM1 mRNA level and transcriptional activity|Finally|In the present study we identified SHP (small heterodimer partner) as a nuclear receptor that decreased the expression of Gli target genes by repressing the transcriptional activity of Gli1.|These findings demonstrate that TCF4 anomalies are responsible for PHS and provide the first evidence of a human disorder related to class I basic helix-loop-helix transcription-factor defects (also known as "E proteins").|We subsequently identified two de novo heterozygous missense mutations of a conserved amino acid in the basic region of the TCF4 gene in three additional subjects with PHS.	TP|TP|TP|TP|FP|FP	database|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|general or irrelevant information|general or irrelevant information	20024066||||17436254|
TP63	TP63|ARHGAP24|TP63|TP63|TP63|TP63|CYP27B1|CYP27B1|TP63|ARHGAP24|PPARA|TP63|PPARA|FOXO4|FOXO4|GATA3|TP63|TP63|ARHGAP24|TP63|TP63|TP63|TP63|CYP27B1|CYP27B1|TP63|ARHGAP24|PPARA|TP63|PPARA|FOXO4|FOXO4|GATA3|TP63|TP53BP1|TP53BP1|GLI1|ESR1|ESR1	However|TA-p73/p63 demonstrate p53-like properties including gene transactivation and cell death promotion|TA-p73/p63 demonstrate p53-like properties including gene transactivation and cell death promotion|Taken together|In contrast|DeltaNp63 transcriptionally regulates ATM to control p53 Serine-15 phosphorylation.|In conclusion|In conclusion|Transcriptional activity of TAp63 promoter is regulated by c-jun.|In vivo co-transfection assays of the ability of p53 and its homologues to activate reporter genes showed that a DNA-binding mutant of p53 was not able to act in a dominant negative manner over wild-type p73 or p63 but that a p73 mutant could inhibit the activity of wild-type p63.|Distinct PPARalpha transcripts are differentially regulated by p63|Furthermore|Silencing of p63 by RNA interference and transient transfections showed that p63 represses PPARalpha through a functional region of promoter B.|All 10 SCSCC showed strong expression of p63|Overall|One of 2 proliferating Brenner tumors was positive for S100P|Twenty-nine percent of ACA were at least focally p63+; 12% were Sox2+/p63+.|However|TA-p73/p63 demonstrate p53-like properties including gene transactivation and cell death promotion|TA-p73/p63 demonstrate p53-like properties including gene transactivation and cell death promotion|Taken together|In contrast|DeltaNp63 transcriptionally regulates ATM to control p53 Serine-15 phosphorylation.|In conclusion|In conclusion|Transcriptional activity of TAp63 promoter is regulated by c-jun.|In vivo co-transfection assays of the ability of p53 and its homologues to activate reporter genes showed that a DNA-binding mutant of p53 was not able to act in a dominant negative manner over wild-type p73 or p63 but that a p73 mutant could inhibit the activity of wild-type p63.|Distinct PPARalpha transcripts are differentially regulated by p63|Furthermore|Silencing of p63 by RNA interference and transient transfections showed that p63 represses PPARalpha through a functional region of promoter B.|All 10 SCSCC showed strong expression of p63|Overall|One of 2 proliferating Brenner tumors was positive for S100P|Twenty-nine percent of ACA were at least focally p63+; 12% were Sox2+/p63+.|Unlike in TP53 gene|Unlike in TP53 gene|We evaluated amplification and overrepresentation of CDK4|OBJECTIVES: To investigate whether: 1) PvuII and XbaI polymorphisms in ESR1 are predisposition factor for AIS and 2) these polymorphisms correlate with the severity of curvature in AIS.|The effect of ESR1 SNPs on severity of scoliosis was analyzed in a subgroup of AIS patients (n = 364) followed up until skeletal maturity with the maximum Cobb angle recorded.	TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|FP|FP|FP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|FP|FP|FP|TP|TP|FP|FP|FP	database|database|database|database|database|database|potential direct influence on expression|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|incorrectly recognized gene name or identifier|general or irrelevant information|general or irrelevant information|database|database|database|database|database|database|potential direct influence on expression|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|incorrectly recognized gene name or identifier|general or irrelevant information|general or irrelevant information|database|database|general or irrelevant information|general or irrelevant information|general or irrelevant information	11181451|11546792|17903252|17164413||||||||||||||11181451|11546792|17903252|17164413||||||||||||||18348649||15024701|17023856|
IRF1	IRF1|MYB|IRF2|IRF1|NFKB1|IRF2|IRF2|IRF2|IRF2|IRF1|NFKB1|IRF1|IRF2|STAT3	Together|Together|Two well-studied members of this family|Here we report that IRF-1-mediated IFN-beta induction depends on NFkappaB activity.|IRF-1 by itself initiates NFkappaB activation by inducing a reduction in cellular MAD3/IkappaBalpha|Interferon regulatory factor-2 (IRF-2)|In addition|IRF-1 also induced expression of its homologous repressor IRF-2 as indicated by EMSA analysis using an IRF-E probe from the IRF-2 promoter; and by cotransfection of IRF-1 together with an IRF-2 promoter CAT construct.|Therefore|Therefore|These studies show that NFkappaB plays an important role in the regulation of IRF-1 induction in HUVECs.|These studies show that NFkappaB plays an important role in the regulation of IRF-1 induction in HUVECs.|We also analyzed the effect of over-expressing IRF-2 on CAT reporter gene expression driven by mutant H4 promoters and assessed H4 transcriptional control in cells nullizygous for IRF-1 and IRF-2.|Thus	TP|TP|NN|NN|TP|NN|TP|TP|TP|TP|TP|TP|FP|TP	database|database|cooperation/competition in transcription|cooperation/competition in transcription|binding to regulatory DNA-region/potential direct influence on expression|cooperation/competition in transcription|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|incorrectly recognized gene name or identifier|database	10739671|11524479|10215868|18395009|7579440.0|9054665|9540062|||||||17202361
JUN	JUN|JUN|JUN|JUN|JUN|JUN|MEF2A|JUN|FOSB|JUN|IL10|YBX1|JUN|TBP|JUN|TBP|JUN|JUN|TAF1|CYP27B1|CYP27B1|HIF1A|CREB1|NCOA3|JUN|JUN|JUN|RARA|HNF4A	c-Jun inhibits transforming growth factor beta-mediated transcription by repressing Smad3 transcriptional activity.|Moreover|The repression obtained with a c-Jun mutant unable to activate transcription through AP-1 sites indicates that the inhibitory mechanism does not rely on the induction of a Smad3 repressor by c-Jun|Mutational analyses of the c-Jun protein and the AP-1 binding site in the promoter revealed that the interaction of c-Jun with DNA is necessary for transcriptional activation by TGF-beta and Smad3.|Mutational analyses of the c-Jun protein and the AP-1 binding site in the promoter revealed that the interaction of c-Jun with DNA is necessary for transcriptional activation by TGF-beta and Smad3.|In KB-3 cells|Interestingly|On the other hand|Using both artificial constructs specific for either the Smad or AP-1 signaling pathways or natural promoters known to be TGF-beta-responsive|Interestingly|Interestingly|Altogether|In support of this hypothesis|In support of this hypothesis|Moreover|Moreover|We hypothesized that c-Jun is capable of derepressing the effect of the TAF(II)250 N terminus on TFIID-driven transcription.|We hypothesized that c-Jun is capable of derepressing the effect of the TAF(II)250 N terminus on TFIID-driven transcription.|We hypothesized that c-Jun is capable of derepressing the effect of the TAF(II)250 N terminus on TFIID-driven transcription.|Both the p38 and JNK MAPK pathways and the downstream transcription factor c-Jun/AP-1 are required for the VDR stimulation|Both the p38 and JNK MAPK pathways and the downstream transcription factor c-Jun/AP-1 are required for the VDR stimulation|The stabilization of HIF-1alpha was dependent on the domains of c-Jun for DNA binding and heterodimerization but independent of the Ser(63/73) phosphorylation that is critical for transcriptional function.|Similar to CREB-mediated transcription|However|Therefore|Retinoids|Some of the therapeutic actions of retinoids can be ascribed to retinoic acid receptor (RAR)-mediated antagonism of AP1-dependent gene expression.|To gain insight into the molecular mechanism of RAR-AP1 interaction|Finally	TP|TP|TP|TP|TP|TP|TP|TP|TP|NN|NN|NN|TP|TP|TP|TP|FP|FP|FP|TP|TP|TP|FP|FP|TP|TP|TP|TP|FP	database|database|database|database|database|database|database|database|database|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|incorrectly recognized gene name or identifier	10995748|10995748|18094076|10903323|18448277|19584293|8383624|11371641|12917425|11983707|15623506|19738058|16860316|18219112|18607069||||||||||10329471||||19131506
DDIT3	ATF6|DDIT3|ATF2|ATF4|ATF2|ATF4|ATF4|DDIT3|JUN|FOSB|ETS1|ETS1|DDIT3|ETS1	We report here that overexpression of soluble ATF6 activates transcription of the CHOP and XBP-1 genes as well as of ER chaperone genes constitutively|Induction of CHOP expression by amino acid limitation requires both ATF4 expression and ATF2 phosphorylation.|Among all these transcription factors|Among all these transcription factors|We show that inhibition of ATF2 or ATF4 expression impairs the transcriptional activation of CHOP by amino acid starvation.|We show that inhibition of ATF2 or ATF4 expression impairs the transcriptional activation of CHOP by amino acid starvation.|Furthermore|These results suggest that the presence of mtDNA mutations elicits upregulation of CHOP and ASNS genes through the elevation of ATF4 expression and its binding to the AARE and NSRE-1|Chalcone was the only phytochemical that activated all three transcription factors [Elk-1|Finally|In addition|Our results also demonstrate how ETS1 and FLI-1 specifically regulate GADD153 expression.|Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.|The ETS1 and FLI-1 proteins provide a novel mechanism of activation for GADD153	TP|NN|TP|TP|TP|TP|TP|TP|FP|TP|TP|TP|TP|TP	database|cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|general or irrelevant information|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression	10958673|14630918|17276738|12097658|18313712|||||8670069|10510472|19922526||
TP73	E2F1|ARHGAP24|ARHGAP24|TP53BP1|TP53BP1|ARHGAP24|E2F1|E2F1|ARHGAP24|ARHGAP24|TP53BP1|TP53BP1|ARHGAP24|ARHGAP24|ARHGAP24|FBXW11|FBXW11|MYC|MYC|ARHGAP24|ARHGAP24|ARHGAP24|LEF1|E2F1|E2F1|ETV4	Here we provide evidence that E2F1 directly activates transcription of TP73|Disruption of p73 function by a tumour-derived p53 mutant reduced E2F1-mediated apoptosis.|Disruption of p73 function by a tumour-derived p53 mutant reduced E2F1-mediated apoptosis.|Molecular analysis of the TP73 gene on 1p36 and the TP53 gene revealed a deletion of one-allele in TP73 with partial demethylation of another allele in the initial clone of YSK|Although the TP53 gene is frequently mutated in human cancers|The p73alpha protein is a functional homolog of the p53 tumor suppressor.|DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.|Furthermore|DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.|DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.|Unlike in TP53 gene|Unlike in TP53 gene|Our results suggest that regulation of p73 expression is primarily mediated through binding of E2F1 to target sites at -155 and -132.|Namely|Namely|Namely|Namely|c-Myc-regulated microRNAs modulate E2F1 expression.|These findings expand the known classes of transcripts within the c-Myc target gene network|We show that DeltaNp73 antagonizes the repressive effect of the proapoptotic p53 family members on hTERT expression and|We show that forced expression of p73 or activation of endogenous p73 by E2F1 results in the downregulation of telomerase activity.|The results presented here suggested the cooperative transcriptional regulation of p73 by YY1 and E2F1|LEF-1 activates the transcription of E2F1.|DNA damage by etoposide causes E2F1-dependent induction of E1AF expression at transcriptional level.|Here|Furthermore	TP|TP|TP|TP|TP|TP|p73 is a member of the p53 family often overexpressed in human cancer.|TP|p73 is a member of the p53 family often overexpressed in human cancer.|p73 is a member of the p53 family often overexpressed in human cancer.|TP|TP|TP|TP|TP|FP|FP|TP|TP|TP|TP|TP|TP|TP|TP|FP	database|database|database|database|database|database|TP|database|TP|TP|database|database|database|database|potential direct influence on expression|incorrectly recognized gene name or identifier|incorrectly recognized gene name or identifier|database|database|database|database|database|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|general or irrelevant information	11101847|11550287|12716888|18348649|11988839|12789260|15944709|16205639|17784791|17980704|18345030|19603422|19629135|19806017|15313206|17980157|18687701|16037820|15190206|12909334|20338640|||||
SRY	WT1|SRY|SRY|WT1|SRY|WT1|SOX9	These observations|In this study we investigated the regulation of the sex determination gene SRY by WT1.|The human sex-determining gene SRY is a direct target of WT1.|Wildtype WT1 is recruited to SRY-binding sites in an SRY-dependent manner|Transcriptional activity of testis-determining factor SRY is modulated by the Wilms' tumor 1 gene product|The WT1 transcription factor regulates SRY expression during the initial steps of the sex determination process in humans|The normal role of SRY in gonadal development is the upregulation of SOX9 expression.	TP|TP|TP|TP|TP|TP|TP	database|database|database|database|database|database|potential direct influence on expression	11278460|12970737|15665984.0|19513096|||
HNF4A	ONECUT1|HNF1A|HNF1A|FOXA2|HNF4A|NR1I2|NR0B2|NR1I2|NR1I2|SREBF2|ONECUT1|ONECUT1|ONECUT1|JUN|NR1I2|CASR|NR1I2|NR1I2|HNF1A|HNF4A|PPARA|NR2F1|HOXB13|HOXB13|TCF7L2|LEF1|LEF1|LEF1|LEF1|LEF1|FOSB|LEF1|MYC|HNF4A|TCF4|UBTF|NR1I2|NR1I2	We screened HNF-6 gene for mutations in 34 Japanese subjects with MODY/early-onset diabetes mellitus and 56 subjects with late-onset diabetes mellitus.|AIMS/HYPOTHESIS: The aim of this study was to examine the prevalence and nature of mutations in HNF4alpha/MODY1|CONCLUSION: This study suggests that mutations in the HNF1A gene comprise about 9% of clinically diagnosed MODY subjects in southern India and a novel Arg263His mutation cosegregates with MODY in one family|The results of our study suggest that mutations in HNF3B are not a common cause of MODY in Japanese subjects|We have tested this hypothesis by screening a panel of 57 unrelated Japanese subjects with a clinical diagnosis of MODY for mutations in HNF3B.|PXR concomitantly inhibits SHP gene transcription and maximizes the PXR induction of the CYP3A4 gene in human livers.|On the other hand|On the other hand|Results suggest that PXR strongly induces CYP3A4 gene transcription by interacting with HNF4alpha|RESULTS: Transfection of SREBP2 induced the transcriptional activities of NPC1L1 and additional transfection of HNF4alpha results in a marked stimulation of the activities.|Using transient transfection assays|In this study|Our results suggest that HNF-6 is a novel target of SHP in the regulation of gluconeogenesis|Taken together|As the transcriptional activity of PXR and CAR is not affected by IL-6 in cell-based reporter assays|As the transcriptional activity of PXR and CAR is not affected by IL-6 in cell-based reporter assays|In this study|These results suggested that HNF4alpha transactivated the human PXR gene by binding to the DR1 element located at -88/-76 of the promoter and was involved in the expression of PXR in the human liver|The mechanism by which HNF1-mediated activation occurs seems to be transcriptional|The mechanism by which HNF1-mediated activation occurs seems to be transcriptional|Because PPARalpha levels are elevated in tissues expressing the hepatocyte nuclear factor-4 (HNF4)|Additionally|In prostate cancers|TCF4 promoter analysis showed that HOXB13 does not regulate TCF4 at the transcriptional level.|However|Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.|Nuclear LEF-1/TCF expression was observed in 52% of all cases|These data indicate that the hAR gene is a direct target of LEF-1/TCF transcriptional regulation in PCa cells but also show that the expression of the hAR protein is suppressed by a degradation pathway regulated by cross-talk of Wnt to Akt that is likely mediated by Wnt-directed degradation of the B regulatory subunit of protein phosphatase|Finally|Wnt is a complex signaling pathway whose endpoint involves activation of transcription from LEF-1/TCF transcription factors and it is known to be involved in the development and progression of numerous human epithelial tumors including prostate cancer.|Physical and functional cooperation between AP-1 and beta-catenin for the regulation of TCF-dependent genes.|Aberrant activations of LEF1/TCF-mediated transcription have been implicated in a variety of malignancies.|Thus|We conclude that p62TCF is composed of Elk-1|Human cancers with beta-catenin regulatory defects had elevated ITF-2 expression|Downregulation of endogenous UBF expression using an RNA interference approach reduces transcriptional activation of a beta-catenin-LEF/TCF-responsive promoter by means of overexpressed beta-catenin|In this study|These results suggested that HNF4alpha transactivated the human PXR gene by binding to the DR1 element located at -88/-76 of the promoter and was involved in the expression of PXR in the human liver	TP|TP|TP|FP|FP|TP|TP|NN|NN|NN|NN|TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|NN|NN|FP|FP|NN|NN|NN|NN|NN|NN|NN|TP|FP|FP|FP|TP|TP	database|database|database|general or irrelevant information|general or irrelevant information|database|database|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|database|database|database|cooperation/competition in transcription|cooperation/competition in transcription|negative statement|general or irrelevant information|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	11323086|12627330|19336507|14694850||16455805|18080173|18459945|15292277|10924340|18305375|16895524|||||||16670373|11981036|8810289||19966299|8083237|12086873|12748295|17929268||||||||||18305375|
NR4A2	CREB1	In summary	TP	database	11884470
GLI1	GLI1|GLI1|GLI2|GLI1|GLI1|GLI2|GLI2|GLI2|SOX9|SOX14|JUN|JUN|DDIT3|DDIT3	Cooperative E-box regulation of human GLI1 by TWIST and USF.|Cooperative E-box regulation of human GLI1 by TWIST and USF.|Detailed time course experiments monitoring the transcriptional response of keratinocytes either to GLI1 or to GLI2 suggest that GLI1 is a direct target of GLI2|Detailed time course experiments monitoring the transcriptional response of keratinocytes either to GLI1 or to GLI2 suggest that GLI1 is a direct target of GLI2|Expression of GLI1 in human keratinocytes induced the transcriptional activator isoforms GLI2alpha and GLI2beta.|GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter.|These data suggest that GLI2 directly activates GLI1 and that retrovirally expressed GLI2 induces expression of endogenous GLI1 in human primary keratinocytes.|MAP3K10-induced DYRK2 phosphorylation combined with SUFU inhibition results in the stabilization and nuclear accumulation of GLI2 for transcriptional activation of GLI1|In silico studies identify a putative binding site within SOX9cre1 for GLI1|Further|The synergistic effect of GLI and JUN extends to the activation of further GLI target genes as shown by shRNA-mediated knockdown of JUN in human keratinocytes.|Transcription of JUN is greatly enhanced in the presence of GLI and requires activated JUN protein.|The CHOP/GADD153 gene|The CHOP/GADD153 gene	TP|TP|TP|TP|TP|TP|TP|TP|TP|TP|NN|NN|FP|FP	database|database|database|database|database|database|database|database|binding to regulatory DNA-region|potential direct influence on expression|cooperation/competition in transcription|cooperation/competition in transcription|general or irrelevant information|general or irrelevant information	15175043|18813803|17409199|20074681|||||||19219074|8076941||
TWIST1	GLI1|GLI1|GLI2|GLI1|GLI1|GLI2|GLI2|GLI2|SOX9|SOX14	Cooperative E-box regulation of human GLI1 by TWIST and USF.|Cooperative E-box regulation of human GLI1 by TWIST and USF.|Detailed time course experiments monitoring the transcriptional response of keratinocytes either to GLI1 or to GLI2 suggest that GLI1 is a direct target of GLI2|Detailed time course experiments monitoring the transcriptional response of keratinocytes either to GLI1 or to GLI2 suggest that GLI1 is a direct target of GLI2|Expression of GLI1 in human keratinocytes induced the transcriptional activator isoforms GLI2alpha and GLI2beta.|GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter.|These data suggest that GLI2 directly activates GLI1 and that retrovirally expressed GLI2 induces expression of endogenous GLI1 in human primary keratinocytes.|MAP3K10-induced DYRK2 phosphorylation combined with SUFU inhibition results in the stabilization and nuclear accumulation of GLI2 for transcriptional activation of GLI1|In silico studies identify a putative binding site within SOX9cre1 for GLI1|Further	TP|TP|TP|TP|TP|TP|TP|TP|TP|TP	database|database|database|database|database|database|database|database|binding to regulatory DNA-region|potential direct influence on expression	15175043|18813803|17409199|20074681||||||
GLI2	GLI2|GLI1|GLI1	Detailed time course experiments monitoring the transcriptional response of keratinocytes either to GLI1 or to GLI2 suggest that GLI1 is a direct target of GLI2|Detailed time course experiments monitoring the transcriptional response of keratinocytes either to GLI1 or to GLI2 suggest that GLI1 is a direct target of GLI2|Expression of GLI1 in human keratinocytes induced the transcriptional activator isoforms GLI2alpha and GLI2beta.	TP|TP|TP	database|database|database	12165851||
HOXB7	HOXB7	HOXB7 expression is regulated by the transcription factors NF-Y	TP	database	
SOX10	SOX10|MITF|MITF	A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes.|M-MITF promoter responsiveness to cAMP was found to depend upon SOX10|Our findings suggest that altered MITF function during melanomagenesis can be achieved by MITF amplification	TP|TP|TP	database|database|database	12944398|19422606|16921166
PPARA	HIF1A|HIF1A|HIF1A|HIF1A|ARNTL|CLOCK|ARNTL|CLOCK|STAT3|FOXO4|NR1I2|PPARA|TP63|PPARA|SOX9|PPARG|FOSB|TP53|STAT3|ARNTL|CLOCK|ARNTL|CLOCK|PPARA|PPARG|PAX8|PPARG|PPARG|RXRB	Influence of hypoxia on peroxisome proliferator activated receptor alpha and its mechanisms|The influence of antisense oligonucleotide HIF-1alpha on PPAR-alpha was detected by RT-PCR and Western-blot.|HIF-1alpha displaces the transcriptional activator Myc from Sp1 binding to repress MutSalpha expression in a p53-dependent manner; Sp1 serves as a molecular switch by recruiting HIF-1alpha to the gene promoter under hypoxia.|HIF-1alpha displaces the transcriptional activator Myc from Sp1 binding to repress MutSalpha expression in a p53-dependent manner; Sp1 serves as a molecular switch by recruiting HIF-1alpha to the gene promoter under hypoxia.|We also found that CLOCK/BMAL1-mediated transcription of period (PER) and cryptochrome (CRY) was modulated by PPARalpha/RXRalpha.|We also found that CLOCK/BMAL1-mediated transcription of period (PER) and cryptochrome (CRY) was modulated by PPARalpha/RXRalpha.|To investigate the interaction between the lipid metabolism system and the circadian system|To investigate the interaction between the lipid metabolism system and the circadian system|Interestingly|FOXO4 induces human plasminogen activator inhibitor-1 gene expression via an indirect mechanism by modulating HIF-1alpha and CREB levels.|Further analysis of this regulatory region has shown that transcriptional activation of PXR by peroxisome proliferator-activated receptor alpha (PPARalpha) is via a binding site located approximately 1.3 kb upstream of the putative transcription start site|Distinct PPARalpha transcripts are differentially regulated by p63|Furthermore|Silencing of p63 by RNA interference and transient transfections showed that p63 represses PPARalpha through a functional region of promoter B.|RESULTS: We found that hypoxia and HIF-1alpha not only induced the expression of SOX9|Whereas PPARgamma promotes lipid storage by regulating adipocyte differentiation|These data suggest that AP-1 is likely to be located at the crossroads between LDL signaling and the regulation of IL-8 modulation by PPARalpha|RESULTS: Under the condition of normal concentration oxygen|Nuclear location was a proof of activity of STAT3 and HIF-1 and it was mainly characteristic for granular anti-STAT3 staining and rarely for diffuse HIF-1alpha expression.|We also found that CLOCK/BMAL1-mediated transcription of period (PER) and cryptochrome (CRY) was modulated by PPARalpha/RXRalpha.|We also found that CLOCK/BMAL1-mediated transcription of period (PER) and cryptochrome (CRY) was modulated by PPARalpha/RXRalpha.|To investigate the interaction between the lipid metabolism system and the circadian system|To investigate the interaction between the lipid metabolism system and the circadian system|Therefore|Therefore|PAX8-PPARgamma1 mRNA and protein were detected in 5 of 8 thyroid follicular carcinomas but not in 20 follicular adenomas|In protease protection assays|This observation suggests the possibility that PPARalpha and PPARgamma activators|A Val95Ala polymorphism of the RXRB gene	OBJECTIVE: To study the expressions of peroxisome proliferator activated receptor alpha (PPAR-alpha) and hypoxia-inducible factor-1alpha (HIF-1alpha) during different hypoxia states in lung cancer cell A549|TP|TP|TP|NN|NN|FP|FP|NN|TP|TP|TP|TP|TP|TP|FP|FP|FP|FP|NN|NN|FP|FP|TP|FP|FP|FP|FP|FP	TP|database|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|cooperation/competition in transcription|cooperation/competition in transcription|general or irrelevant information|general or irrelevant information|cooperation/competition in transcription|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|cooperation/competition in transcription|cooperation/competition in transcription|general or irrelevant information|general or irrelevant information|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information	14521756|15780936|20136501|14604972|20110263|9655393|11727934|11819031|14992692|15120605|18579174|19549358||||||||18317514|12191966|10678274|10854698|10958784.0|12079871||||11840500
HIF1A	HIF1A|HIF1A|HIF1A|HIF1A|ARNTL|CLOCK|ARNTL|CLOCK|STAT3|FOXO4|NR1I2|PPARA|TP63|PPARA|SOX9|PPARG|FOSB|TP53|STAT3	Influence of hypoxia on peroxisome proliferator activated receptor alpha and its mechanisms|The influence of antisense oligonucleotide HIF-1alpha on PPAR-alpha was detected by RT-PCR and Western-blot.|HIF-1alpha displaces the transcriptional activator Myc from Sp1 binding to repress MutSalpha expression in a p53-dependent manner; Sp1 serves as a molecular switch by recruiting HIF-1alpha to the gene promoter under hypoxia.|HIF-1alpha displaces the transcriptional activator Myc from Sp1 binding to repress MutSalpha expression in a p53-dependent manner; Sp1 serves as a molecular switch by recruiting HIF-1alpha to the gene promoter under hypoxia.|We also found that CLOCK/BMAL1-mediated transcription of period (PER) and cryptochrome (CRY) was modulated by PPARalpha/RXRalpha.|We also found that CLOCK/BMAL1-mediated transcription of period (PER) and cryptochrome (CRY) was modulated by PPARalpha/RXRalpha.|To investigate the interaction between the lipid metabolism system and the circadian system|To investigate the interaction between the lipid metabolism system and the circadian system|Interestingly|FOXO4 induces human plasminogen activator inhibitor-1 gene expression via an indirect mechanism by modulating HIF-1alpha and CREB levels.|Further analysis of this regulatory region has shown that transcriptional activation of PXR by peroxisome proliferator-activated receptor alpha (PPARalpha) is via a binding site located approximately 1.3 kb upstream of the putative transcription start site|Distinct PPARalpha transcripts are differentially regulated by p63|Furthermore|Silencing of p63 by RNA interference and transient transfections showed that p63 represses PPARalpha through a functional region of promoter B.|RESULTS: We found that hypoxia and HIF-1alpha not only induced the expression of SOX9|Whereas PPARgamma promotes lipid storage by regulating adipocyte differentiation|These data suggest that AP-1 is likely to be located at the crossroads between LDL signaling and the regulation of IL-8 modulation by PPARalpha|RESULTS: Under the condition of normal concentration oxygen|Nuclear location was a proof of activity of STAT3 and HIF-1 and it was mainly characteristic for granular anti-STAT3 staining and rarely for diffuse HIF-1alpha expression.	OBJECTIVE: To study the expressions of peroxisome proliferator activated receptor alpha (PPAR-alpha) and hypoxia-inducible factor-1alpha (HIF-1alpha) during different hypoxia states in lung cancer cell A549|TP|TP|TP|NN|NN|FP|FP|NN|TP|TP|TP|TP|TP|TP|FP|FP|FP|FP	TP|database|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|cooperation/competition in transcription|cooperation/competition in transcription|general or irrelevant information|general or irrelevant information|cooperation/competition in transcription|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information	14521756|15780936|20136501|14604972|20110263|9655393|11727934|11819031|14992692|15120605|18579174|19549358|||||||
PAX8	GATA1|GATA1|PAX2|PAX8|WT1|WT1|PAX2	In conclusion|PAX2|PAX2|PAX2|Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias.|Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias.|In contrast to PAX2	TP|TP|TP|TP|TP|TP|FP	database|database|database|database|database|database|general or irrelevant information	14531904.0|19525927|||||
MYCN	MDM2|MYCN|MYCN|RARA	BACKGROUND: MDM2 is a major negative regulator of p53 function and is directly regulated by MYCN in neuroblastoma (NB) cells.|We concluded that MYCN transcriptionally upregulates p53 in neuroblastoma and uses p53 to mediate a key mechanism of apoptosis|Unexpectedly|Any association of per se inactive RXR-selective with RAR-selective ligands efficiently regulates growth inhibition	TP|TP|TP|TP	potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|potential direct influence on expression	17363562|||9334253
REST	HES1|HES1|REST|NKX2-1	Moreover|Taken together|In this study|Chromatin-immunoprecipitation experiments demonstrate the recruitment of BHC by the neuronal repressor REST.	TP|TP|TP|NN	database|database|database|cooperation/competition in transcription	16253247|12032298||
HES1	HES1|HES1|REST|NKX2-1	Moreover|Taken together|In this study|Chromatin-immunoprecipitation experiments demonstrate the recruitment of BHC by the neuronal repressor REST.	TP|TP|TP|NN	database|database|database|cooperation/competition in transcription	16253247|12032298||
NFKB1	NFKB1|ARHGAP24|NFKB1|NFKB1|HIF1A|IRF1|NFKB1|FOSB|IRF1|NFKB1|IRF1|FOXP1|NFKB1|E2F1|NFKB1|CASR	Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells.|Using p53 null cell lines|In addition|We found in agreement with a recent report showing that NFkappaB is required for the efficient activation of the BH3-only protein Noxa by the p53 family member p73|The ability of MDAs to induce HIF-1alpha is dependent upon activation of NFkappaB|Here we report that IRF-1-mediated IFN-beta induction depends on NFkappaB activity.|IRF-1 by itself initiates NFkappaB activation by inducing a reduction in cellular MAD3/IkappaBalpha|In Jurkat and HeLa cells|The GAS/kappaB element may mediate synergistic transcriptional induction of IRF-1 by other pairs of ligands that together activate NFkappaB and STAT family members.|These studies show that NFkappaB plays an important role in the regulation of IRF-1 induction in HUVECs.|These studies show that NFkappaB plays an important role in the regulation of IRF-1 induction in HUVECs.|FOXP1 is a transcriptional repressor that has been proposed to repress the expression of some NFkappaB-responsive genes.|These data suggest that NF-kappaB-dependency of the PAF-induced increase in VEGF expression is due to decreased p53 activity|In vitro transcription assay demonstrates that E2F-1 represses NF-kappaB mediated transcription in a cell-free system.|Bcl-3 is an unusual IkappaB protein because it is primarily nucleoplasmic and can lead to enhanced NF-kappaB-dependent transcription|In conclusion	TP|TP|TP|TP|TP|NN|TP|TP|TP|TP|TP|TP|TP|NN|TP|TP	database|database|database|database|database|cooperation/competition in transcription|binding to regulatory DNA-region/potential direct influence on expression|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|database|cooperation/competition in transcription|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	20160496|9665319|12356823|12432072|19707556||||||||16684540|15382119||
NR0B2	NR1I2|NR0B2|NR1I2|NR1I2|SREBF2|ONECUT1|ONECUT1|ONECUT1|JUN|NR1I2|CASR|NR1I2|NR1I2	PXR concomitantly inhibits SHP gene transcription and maximizes the PXR induction of the CYP3A4 gene in human livers.|On the other hand|On the other hand|Results suggest that PXR strongly induces CYP3A4 gene transcription by interacting with HNF4alpha|RESULTS: Transfection of SREBP2 induced the transcriptional activities of NPC1L1 and additional transfection of HNF4alpha results in a marked stimulation of the activities.|Using transient transfection assays|In this study|Our results suggest that HNF-6 is a novel target of SHP in the regulation of gluconeogenesis|Taken together|As the transcriptional activity of PXR and CAR is not affected by IL-6 in cell-based reporter assays|As the transcriptional activity of PXR and CAR is not affected by IL-6 in cell-based reporter assays|In this study|These results suggested that HNF4alpha transactivated the human PXR gene by binding to the DR1 element located at -88/-76 of the promoter and was involved in the expression of PXR in the human liver	TP|TP|NN|NN|NN|NN|TP|TP|TP|TP|TP|TP|TP	database|database|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	16455805|18080173|18459945|15292277|10924340|18305375|16895524||||||
NR1I2	NR1I2|NR0B2|NR1I2|NR1I2|SREBF2|ONECUT1|ONECUT1|ONECUT1|JUN|NR1I2|CASR|NR1I2|NR1I2	PXR concomitantly inhibits SHP gene transcription and maximizes the PXR induction of the CYP3A4 gene in human livers.|On the other hand|On the other hand|Results suggest that PXR strongly induces CYP3A4 gene transcription by interacting with HNF4alpha|RESULTS: Transfection of SREBP2 induced the transcriptional activities of NPC1L1 and additional transfection of HNF4alpha results in a marked stimulation of the activities.|Using transient transfection assays|In this study|Our results suggest that HNF-6 is a novel target of SHP in the regulation of gluconeogenesis|Taken together|As the transcriptional activity of PXR and CAR is not affected by IL-6 in cell-based reporter assays|As the transcriptional activity of PXR and CAR is not affected by IL-6 in cell-based reporter assays|In this study|These results suggested that HNF4alpha transactivated the human PXR gene by binding to the DR1 element located at -88/-76 of the promoter and was involved in the expression of PXR in the human liver	TP|TP|NN|NN|NN|NN|TP|TP|TP|TP|TP|TP|TP	database|database|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	16455805|18080173|18459945|15292277|10924340|18305375|16895524||||||
PDX1	TTF1	All rectal carcinoids were negative for CDX-2 and TTF-1; 2/12 were positive for PDX-1	FP	general or irrelevant information	19065104
SCLY	GATA1	Here	TP	database	18082606
ASCL1	HES1	There was a significant positive correlation between NOTCH1 and HES1 mRNA levels	TP	database	18491256
REL	NFKB1	Promoter analysis suggests the implication of NFkappaB/C-Rel transcription factors in biliary atresia.	TP	database	18795655
NFKBIA	RELA	We analysed RELA	TP	database	19129371
TFAP2A	TFAP2A|TFAP2A|TFAP2A	Chromatin immunoprecipitation assays demonstrated that AP-2 proteins bound to a cluster of AP-2 binding sites located within a 2 kb upstream regulatory region of c-myc These results suggest that the negative regulation of AP-2 on c-MYC activity was achieved through binding of AP-2 protein to the c-myc gene.|In addition|The effects of AP-2 on c-MYC were active at several levels.	TP|TP|TP	database|database|database	20066163|11912921|
TTF1	TTF1|TP63	GATA-6|All 23 SCLCs were negative or	TP|FP	binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information	11713256|18091383
ATF3	ATF2|ATF2|ATF4|ATF3	Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways.|Knock down of ATF2 abolished TA-induced ATF3 expression.|The mechanism of ATF3 induction by M344 was found to be independent of MAPKinase pathways and dependent on ATF4|The mechanism of ATF3 induction by M344 was found to be independent of MAPKinase pathways and dependent on ATF4	TP|TP|NN|NN	database|database|cooperation/competition in transcription|cooperation/competition in transcription	20581861|17108111|12718878|
HNF1A	HNF4A|HNF1A|HNF4A|CDX2|HNF4A	Since recent evidence indicates that HNF4 controls HNF1 expression|The mechanism by which HNF1-mediated activation occurs seems to be transcriptional|The mechanism by which HNF1-mediated activation occurs seems to be transcriptional|GATA-5 and CDX2 also regulate SGLT1 promoter activity and show cooperativity with the HNF1s.|One form of maturity-onset diabetes of the young (MODY) results from mutations in a gene	TP|TP|TP|NN|TP	database|database|database|cooperation/competition in transcription|database	8491780|16670373|18656622||8866553
DAND5	SP3|PRDM1|PRDM1|STAT5A	An inhibitory activity of SP3 on the stimulatory effect of SP1 could be confirmed in LRA by contransfection experiments in adipocytes.|Transcription of PRDM1|Transcription of PRDM1|The DNA methylation is induced by NPM1-ALK itself via STAT3	TP|TP|TP|FP	database|binding to regulatory DNA-region|binding to regulatory DNA-region|general or irrelevant information	12378384|18604866|17922009|
SRF	TBP|SRF|ATF6|HESX1	Also of interest was the finding that recombinant human TFIID expressed in bacteria cannot mediate SRF-activated transcription|This supports a model in which SRF activates transcription by affecting the conformation of TFIID bound to the promoter.|More strikingly|This finding was similar to that observed in embryos with cardiac-specific ablation of serum response factor (SRF)	NN|NN|NN|TP	cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|potential direct influence on expression	1909174|9271374|17468179|18714394
STAT3	MYC|MYC|ZFHX3|ZFHX3|STAT1|SREBF1|STAT5A|MYCN|STAT1	Furthermore|Furthermore|In the luciferase assay|We present here experimental evidence that ATBF1 is a new regulatory factor for STAT3-mediated signal transduction through its interaction with PIAS3.|This effect was counteracted by the STAT3 oligodeoxynucleotide|Consistent with these findings|Consequently|Unlike other oncogenes|We further present evidence that STAT1 is activated independently from APRF suggesting that gp130 contains multiple independent STAT binding sites.	TP|TP|NN|NN|NN|TP|FP|FP|FP	database|binding to regulatory DNA-region/potential direct influence on expression|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information	14715251|17461989|19203349|19476491|10356357||||8662591
POLD1	POLD1|POLD1	Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.|When ectopic wild-type p53 expression was induced to a physiologically relevant level in "tet-off" cultured cells in which p53 expression was tightly regulated by tetracycline	TP|TP	database|binding to regulatory DNA-region/potential direct influence on expression	11375983|
NR1H4	PPARA	In concert	TP	database	12554753
E2F4	ARHGAP24|ARHGAP24|FBXW11|FBXW11|TCF7L2|PPARG	Namely|Namely|Namely|Namely|We showed that both beta-catenin and TCF4 bind to the E2F4 3'-UTR site in vivo|We also show that FBI-1 promotes terminal preadipocyte differentiation through a mechanism involving decreased levels of expression of the PPARgamma inhibitor E2F-4.	TP|TP|FP|FP|TP|FP	database|potential direct influence on expression|incorrectly recognized gene name or identifier|incorrectly recognized gene name or identifier|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information	12789260|17121828|17656449|||
EGR1	ARHGAP24|ARHGAP24|ARHGAP24|ARHGAP24|ARHGAP24|VEZF1|SOX18	DeltaNp73 can modulate the expression of various genes in a p53-independent fashion.|Rather|Semiquantitative reverse transcription-PCR confirmed these results and further revealed that the influence of DeltaNp73alpha on the regulation of these genes differs from other p73 isoforms and p53.|We conclude that the impact of DeltaNp73alpha on gene expression is not limited to p53-responsive genes.|For instance|When DB1 was cotransfected with a Tax expression vector|By in vitro binding assays and functional analyses we have shown that these three putative binding sites are functionally relevant and sufficient for EGR1-induced SOX18 transcription.	TP|TP|TP|TP|TP|NN|TP	database|database|database|database|potential direct influence on expression|cooperation/competition in transcription|binding to regulatory DNA-region/potential direct influence on expression	14614448|8035792.0|15548700|20054233|||
CREB1	MITF|SOX9|NR0B1|SREBF1|SREBF1	Up-regulated expression of MITF was found to be mediated via both the mitogen-activated protein kinase-p90 ribosomal S6 kinase-cAMP response element-binding protein (CREB) and cAMP-protein kinase A-CREB pathways.|The action of SOX9 was enhanced by overexpressing CREB.|Herein we report that PGE(2)-induced StAR expression is independent of the transcriptional suppressor DAX-1 but is regulated by the transcriptional activator cyclic adenosine 3'|Clenbuterol inhibits SREBP-1c expression by activating CREB1.|In the present study	TP|TP|FP|TP|FP	database|database|negative statement|potential direct influence on expression|negative statement	18039926|19113914||17669268|
YY1	YBX1|WT1	A yeast interaction trap screen using LexA-YY1 as a bait and a HeLa cell cDNA-acid patch fusion library identified YB-1 as a YY1-interacting protein.|The zinc-finger domains of the predicted protein also showed homology with those of human genes such as WT1	NN|FP	cooperation/competition in transcription|general or irrelevant information	8972186|7789179
ATF6	XBP1|XBP1	pXBP1(U)|We conclude that pXBP1(U) functions as a negative regulator of the UPR-specific transcription factors ATF6 and pXBP1(S).	TP|TP	database|database	19122331|
ZEB1	ARHGAP24|CYP27B1	Employing histological|For instance	TP|FP	database|general or irrelevant information	19194497|16804902
CEBPA	MYC|MYC|FOXA3|RUNX1|RUNX1|RUNX1|RUNX1|KMT2A|KMT2A	Furthermore|Furthermore|In exploring the DNA regions and TRFs involved in combinatorial transcriptional regulation|AML1-ETO appears to suppress C/EBPalpha expression indirectly by inhibiting positive autoregulation of the CEBPA promoter.|AML1-ETO appears to suppress C/EBPalpha expression indirectly by inhibiting positive autoregulation of the CEBPA promoter.|In one of them|The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin.|RECENT FINDINGS: Four prognostic biomarkers-the internal tandem duplication and point mutations in the FLT3 gene|They include internal tandem duplication of the FLT3 gene	TP|TP|TP|FP|FP|FP|FP|FP|FP	database|binding to regulatory DNA-region/potential direct influence on expression|potential direct influence on expression|incorrectly recognized gene name or identifier|incorrectly recognized gene name or identifier|incorrectly recognized gene name or identifier|incorrectly recognized gene name or identifier|general or irrelevant information|general or irrelevant information	19259613|19074951|11283671|12472578|15326310|15604894|17488484||
KLF4	KLF4|KLF4|GPA33|KLF4|CDX2|KLF5|KLF4	KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha.|Therefore|This indicates that PPARgamma activation induces KLF4 expression|We also demonstrate that PPARgamma activation leads to increased (p21WAF1/Cip1 and keratin 19) or decreased (cyclin D1) expression of known KLF4 targets|CDXl|CDXl|KLF4 is activated by p53 following cytostatic	NN|NN|TP|TP|FP|FP|TP	cooperation/competition in transcription|cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression|general or irrelevant information|general or irrelevant information|binding to regulatory DNA-region/potential direct influence on expression	19551868|17308127|17762869||||
TBP	FOXF2|FOSB|JUN|TBP|JUN|TBP|JUN|JUN|TAF1|TAF1|TBP|TAF1|TBP|SRF|JUN|JUN|TBP|JUN|TBP|JUN|JUN|TAF1	The target site for FREAC-2 on TBP was localized to the N-terminal repeat in the core domain of TBP.|These findings suggest that in macrophages|In support of this hypothesis|In support of this hypothesis|Moreover|Moreover|We hypothesized that c-Jun is capable of derepressing the effect of the TAF(II)250 N terminus on TFIID-driven transcription.|We hypothesized that c-Jun is capable of derepressing the effect of the TAF(II)250 N terminus on TFIID-driven transcription.|We hypothesized that c-Jun is capable of derepressing the effect of the TAF(II)250 N terminus on TFIID-driven transcription.|From a functional standpoint|TAF(II)250 is a scaffold for assembly of other TAF(II)s and TBP into TFIID|TAF(II)250 is a scaffold for assembly of other TAF(II)s and TBP into TFIID|Also of interest was the finding that recombinant human TFIID expressed in bacteria cannot mediate SRF-activated transcription|This supports a model in which SRF activates transcription by affecting the conformation of TFIID bound to the promoter.|Interestingly|In support of this hypothesis|In support of this hypothesis|Moreover|Moreover|We hypothesized that c-Jun is capable of derepressing the effect of the TAF(II)250 N terminus on TFIID-driven transcription.|We hypothesized that c-Jun is capable of derepressing the effect of the TAF(II)250 N terminus on TFIID-driven transcription.|We hypothesized that c-Jun is capable of derepressing the effect of the TAF(II)250 N terminus on TFIID-driven transcription.	TP|NN|TP|TP|TP|TP|FP|FP|FP|TP|TP|FP|NN|NN|NN|TP|TP|TP|TP|FP|FP|FP	binding to regulatory DNA-region|cooperation/competition in transcription|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information	9722567|11454854|11316804|11564872|11686293|14506152|||||||1909174|2194667|17996705|7479778|9989412|||||
HOXB4	HOXB4|HOXB4|HOXB4|HOXB4	HOXB4 binds to the c-my c gene at sites involved in blocking c-myc transcription elongation.|The data further establish that HOXB4 levels are regulated by 1|In this study|Taken together	TP|TP|TP|TP	binding to regulatory DNA-region|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|potential direct influence on expression	11250656.0|10085075||
SP3	PRDM1|PRDM1	Transcription of PRDM1|Transcription of PRDM1	TP|TP	binding to regulatory DNA-region|binding to regulatory DNA-region	18604866|
CEBPB	FOSB	Thus	NN	cooperation/competition in transcription	
ETV5	JUN	The synergy between c-Jun and ERM may be attributed to the enhancing effect of c-Jun on the transcription activity of ERM	NN	cooperation/competition in transcription	7559555
UBTF	TBP	Microsequence analysis reveals that the 95-kDa TBP-binding protein is hUBF.	NN	cooperation/competition in transcription	7982918
ETS1	TP63|MAFB|MAFB|SP100|SP100|SP100|SP100|ETV4|ETS1|ETS1|DDIT3|ETS1|GFI1|ETS1|ZEB2|ETS2|TP63|PPARG|WT1	p51 ETS1 is characterized by a fast initial binding and conversion to a stable complex|The KRML (MAFB) transcriptional regulator plays a pivotal role in regulating lineage-specific hematopoiesis by repressing ETS1-mediated transcription of erythroid-specific genes in myeloid cells.|The KRML (MAFB) transcriptional regulator plays a pivotal role in regulating lineage-specific hematopoiesis by repressing ETS1-mediated transcription of erythroid-specific genes in myeloid cells.|SP100 interacts with the ETS1 transcription factor|To further understand the functional relationship between ETS1 and SP100|Collectively|SP100 directly antagonizes ETS1-mediated morphological changes in human umbilical vein endothelial cell (HUVEC) network formation and reduces HUVEC migration and invasion.|The results of these studies indicate that PEA3 is a strong positive regulator of the ETS1 promoter and that other transcription factors increase the activity of the ETS1 promoter in an additive rather than synergistic fashion|In addition|Our results also demonstrate how ETS1 and FLI-1 specifically regulate GADD153 expression.|Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.|The ETS1 and FLI-1 proteins provide a novel mechanism of activation for GADD153|Luciferase (Luc) assays using artificial reporters showed that GFI1 repressed ETS1-mediated transcriptional activation and ETS1 repressed GFI1-mediated transcriptional activation|Luciferase (Luc) assays using artificial reporters showed that GFI1 repressed ETS1-mediated transcriptional activation and ETS1 repressed GFI1-mediated transcriptional activation|Integrative genomic analyses of ZEB2: Transcriptional regulation of ZEB2 based on SMADs|Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1.|Data presented in this paper indicate that the naturally occurring spliced variant protein|The luciferase assay showed that the activation of PPARgamma suppressed -249 to +330 c-MET promoter activity|On a molecular level	NN|NN|NN|NN|NN|FP|FP|TP|TP|TP|TP|TP|TP|TP|TP|FP|FP|NN|TP	cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|general or irrelevant information|general or irrelevant information|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|general or irrelevant information|general or irrelevant information|cooperation/competition in transcription|potential direct influence on expression	8003962|10444328|15592518|18955504|8247540|10510472|17213822|2187191|9266972|||||||||10558888|18212735
TCF12	TAL1	Support for this hypothesis was obtained by transient expression analyses where TAL1 was found to inhibit the activation effects produced by E2-5 and HTF4a on a reporter gene construct containing repeated microE2 and microE5 motifs	NN	cooperation/competition in transcription	8163514
SETD2	STAT3|SETD2|HIF1A|STAT3|ETS1|MYC	STAT3 upregulates expression of HIF-1 induced EPO.|More intriguingly|Vice versa|STAT3 contributes to increase of EPO expression which is also HIF-1 dependent.|These results indicate that hypoxia induces ETS-1 via the activity of HIF-1|In addition	NN|NN|NN|NN|TP|TP	cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression	17684492|11708773|20404562|17482131|11375890|11727934
ONECUT1	FOXM1|ONECUT1	Sequences were inserted at position -21|Human hepatoma (HepG2) cotransfection assays demonstrated that HNF-6 synergistically stimulated FoxA2 but not FoxA1 or FoxA3 transcriptional activity	NN|NN	cooperation/competition in transcription|cooperation/competition in transcription	10333497|12509444
E2F5	PPARG	We also show that FBI-1 promotes terminal preadipocyte differentiation through a mechanism involving decreased levels of expression of the PPARgamma inhibitor E2F-4.	FP	general or irrelevant information	
AHR	RELA	Silencing of RELA expression alleviated IL-1beta-mediated repression of AHR transcriptional activity	NN	cooperation/competition in transcription	18483242
HMGB2	YY1|HMGB1	We show that an element within D4Z4 specifically binds a multiprotein complex consisting of YY1|Molecular phylogenetic analysis shows that LfHMG1 is descended from a gene ancestral to mammalian HMG1 and HMG2.	NN|FP	cooperation/competition in transcription|general or irrelevant information	12176321|9016958
HOXA10	FOXO1|HOXA10	A DNA binding-deficient FKHR mutant fails to stimulate promoter activity|Constitutively expressing HOXA10 in BT20 cells increased p53 protein expression.	NN|TP	cooperation/competition in transcription|binding to regulatory DNA-region/potential direct influence on expression	12493691|
FOXO1	FOXO1|STAT3|STAT3|PAX3|PAX7|PAX7|PAX3|PAX3|PAX3|PAX7|PAX7|PAX7|PAX7|PAX3|PAX3|PAX3|TFAP2B|PAX3|PAX3|PAX3|PAX3|PAX3|PAX7|PAX7|FOXC1|FOXO1|FOXC1|PAX3|PAX7|HIF1A|PAX3	Therefore|Since Akt is known to regulate gene expression through inactivation of the transcription factor FKHR (forkhead in rhabdomyosarcoma)|The effect of FKHR required the presence of functional STAT3 and was abrogated by the expression of dominant negative STAT3 mutants.|The PAX3-FKHR protein was localized to the nucleus in Rh30 cells|The PAX3-FKHR and PAX7-FKHR gene fusions that result from chromosomal translocations in this tumor provide potential molecular diagnostic markers.|Alveolar rhabdomyosarcomas are associated with unique chromosomal translocations t(2;13) and t(1;13)|Molecular analysis with RT-PCR amplification of RNA isolated from the tumour demonstrated the presence of a PAX3/FKHR fusion transcript|These results suggest that at least part of the anti-apoptotic effect of PAX3 and PAX3/FKHR is mediated through direct transcriptional modulation of the prominent anti-apoptotic protein BCL-XL.|CONCLUSIONS: We conclude that compared to PAX7-FKHR-containing tumors|PROCEDURE: We examined histology|Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions.|RESULTS: Cell cycle parameters varied significantly: the number of nuclei that stained with either an immunohistochemical marker of proliferation (MIB1)|The PAX7-FKHR fusion is overexpressed as a result of in vivo amplification while the PAX3-FKHR fusion is overexpressed due to a copy number-independent increase in transcriptional rate.|PAX3/FKHR mutants with deletions in either the homeodomain (DeltaHD) or the FKHR-derived activation domain (DeltaFKHR)|Our study was directed at identifying antigenic T-lymphocyte epitopes at the PAX3/FKHR translocation point area.|These results raise serious concerns about the success and applicability of future peptide-based vaccine immunotherapy directed at the PAX3/FKHR translocation point.|Importantly|We also found repression of skeletal muscle-specific genes suggesting that PAX3/FKHR blocks further differentiation of aRMS cells.|The malignancy of alveolar rhabdomyosarcoma (ARMS) has been linked to expression of the PAX3-FKHR chimeric gene.|We previously showed that PAX3-FKHR expression in primary human myoblasts|Comparative analysis of paired- and homeodomain-specific roles in PAX3-FKHR oncogenesis.|Correspondingly|Correspondingly|Only one case (3%) was positive to t(1;13)/PAX7-FKHR and nine cases (30%) were fusion-negative.|FOXC1 is required for cell viability and resistance to oxidative stress in the eye through the transcriptional regulation of FOXO1A.|Furthermore|FOXC1 regulates the expression of FOXO1A and binds to a conserved element in the FOXO1A promoter in vivo.|Alveolar rhabdomyosarcomas (ARMS) are soft-tissue tumors that are genetically characterized by the presence of reciprocal translocations that generate the fusion gene PAX3-FOXO1A or PAX7-FOXO1A.|Previous studies have suggested that the expression of PAX7-FOXO1A is copy-number dependent|Gene knockdown of HIF-1alpha or FOXO1 by small-interfering RNAs abolishes hypoxia-induced expression of FOXO1 and SUR2A/B/Kir6.1.|Experiments designed to determine how PAX3-FOXO1 expression contributes to the development of muscle cell-derived tumors resulted in the discovery that the fusion protein misregulates gene expression and interrupts myogenic differentiation through a unique gain of function mechanism.	FP|NN|NN|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|TP|TP|TP|FP|FP|TP|FP	general or irrelevant information|indirect interaction|indirect interaction|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|potential direct influence on expression|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|potential direct influence on expression|general or irrelevant information	15688035|9098647|9479491|9516963|9543674|10666368.0|11496344|17525748|18022385|19047133|19158934|20470941|||||||||||||17993506|14697639|17954266|||20212266|18414034
LGALS12	FOSB|FOSB	In the presence of estradiol|Moreover	NN|FP	cooperation/competition in transcription|general or irrelevant information	12554755|
ESRRA	PPARA	At the cellular level	NN	cooperation/competition in transcription	12914524
ATF4	DDIT3|ATF2|ATF4|ATF2|ATF4|ATF3|ATF4|ATF3|ATF4|DDIT3	Induction of CHOP expression by amino acid limitation requires both ATF4 expression and ATF2 phosphorylation.|Among all these transcription factors|Among all these transcription factors|We show that inhibition of ATF2 or ATF4 expression impairs the transcriptional activation of CHOP by amino acid starvation.|We show that inhibition of ATF2 or ATF4 expression impairs the transcriptional activation of CHOP by amino acid starvation.|The data suggest that ATF3-FL and C/EBPbeta act as transcriptional suppressors for the ASNS gene to counterbalance the transcription rate activated by ATF4 following amino acid deprivation|The mechanism of ATF3 induction by M344 was found to be independent of MAPKinase pathways and dependent on ATF4|The mechanism of ATF3 induction by M344 was found to be independent of MAPKinase pathways and dependent on ATF4|Furthermore|These results suggest that the presence of mtDNA mutations elicits upregulation of CHOP and ASNS genes through the elevation of ATF4 expression and its binding to the AARE and NSRE-1	NN|TP|TP|TP|TP|NN|NN|NN|TP|TP	cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|cooperation/competition in transcription|cooperation/competition in transcription|cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression	14630918|15385533|20828393|17276738||||||
RUNX1	RARA|NFE2|RUNX1|ETV6|ETV6|ETV6|ETV6|RUNX1|ETV6|ETV6|ETV6|ETV6|ETV6|RUNX1|ETV6|ETV6|ETV6|RUNX1|ETV6|RUNX1|ETV6|ETV6|ETV6|ETV6|ETV6|ETV6|ETV6|RUNX1|ETV6|KMT2A|ETV6|RUNX1|ETV6|ETV6|ETV6|ETV6|ETV6|HNF4A|ETV6|RUNX1|RUNX1|RUNX1|ETV6|ELF4|ETV6|GFI1|ETV6|RUNX1|RUNX3|RUNX3|RUNX3|RUNX3|RUNX3|RUNX1|RUNX1|RUNX3|RUNX1|RUNX3|ETV6|ETV6|ETV6|ETV6|ETV6|GATA1|ETV6|ETV6|ETV6	In primary AML samples|Our data identify NF-E2 as a novel AML1 target gene and delineate a role for aberrant AML1 expression in mediating elevated NF-E2 expression in MPN patients|RNAi-mediated suppression of either AML1 or of its binding partner CBF-beta significantly decreased NF-E2 expression.|Moreover|In the present study|The t(12;21) translocation is present in up to 30% of childhood B-cell acute lymphoblastic and fuses a potential dimerization motif from the ets-related factor TEL to the N terminus of AML1.|In addition|The reciprocal AML1/TEL transcripts were detected in 12 (86%) of the 14 cases expressing a TEL/AML1 transcript.|The reciprocal AML1/TEL transcripts were detected in 12 (86%) of the 14 cases expressing a TEL/AML1 transcript.|In 14 of these cases (63%)|Percentages of CD13 or CD33 expressing leukaemic cells were found to be higher in TEL-AML1 positive cases (n = 22) than in TEL-AML1 negative (n = 74) cases (P<0.001).|These data show that TEL-AML1 expression is significantly associated with myeloid antigen expression by leukaemic cells and suggests that the prognostic significance of myeloid antigen expression in paediatric ALLs should be re-evaluated in the light of molecular cytogenetic markers.|Lack of TEL/AML1 fusion in pediatric AML: further evidence for lineage specificity of TEL/AML1.|Lack of TEL/AML1 fusion in pediatric AML: further evidence for lineage specificity of TEL/AML1.|This rearrangement results in the in frame fusion of the 5'-region of the ETS-related gene|Although AML1 stimulates transcription|We also show that the leukemia-associated fusion protein TEL/AML1 is modified by SUMO-1 and found in the TEL bodies|We also show that the leukemia-associated fusion protein TEL/AML1 is modified by SUMO-1 and found in the TEL bodies|TEL-AML1 expression was normalized relative to the levels of AML1 transcripts.|DESIGN AND METHODS: The quantitative estimation of TEL-AML1 transcripts was performed in 10 P-ALL TEL-AML1-positive patients.|DESIGN AND METHODS: The quantitative estimation of TEL-AML1 transcripts was performed in 10 P-ALL TEL-AML1-positive patients.|The within-assay coefficient of variation (CV) for TEL-AML1 was 7.0% and the between-assay CV was 13%.|We conclude that the incidence of TEL/AML1 is lower in the Indian population.|CD10+ ancestor cells with germline antigen receptors|We monitored the responses of patients with pediatric acute lymphoblastic leukemia (pALL) using DNA markers|The prognostic significance of the profiles of these genes and the association between alterations in these genes and known cytogenetic prognostic factors (BCR/ABL; ETV6/RUNX1|The prognostic significance of the profiles of these genes and the association between alterations in these genes and known cytogenetic prognostic factors (BCR/ABL; ETV6/RUNX1|The crucial chimeric gene|The crucial chimeric gene|The MLL gene at 11q23 or the AML1 gene at 21q22 are almost uniformly rearranged.|TEL/AML1 transcript and p16 gene deletion in a patient with childhood acute lymphoblastic leukaemia.|The 12;21 chromosomal translocation occurs in leukemic cells from 20(30% of patients with B-lineage childhood acute lymphoblastic leukemia|The 12;21 chromosomal translocation occurs in leukemic cells from 20(30% of patients with B-lineage childhood acute lymphoblastic leukemia|After matching for unevenly distributed patient characteristics-that is|Deletion of 12p resulting in the loss of the normal allele of TEL and nonspecific del(6q) were noted in 8% (1/12) and 25% (3/12) of the TEL/AML1+ children|Here|All fourteen patients positive for TEL/AML1 gene fusion were mosaic.|The induction of plakoglobin by AML fusion proteins led to downstream signaling and transactivation of TCF- and LEF-dependent promoters|TEL deletions|CONCLUSION: High AML1-TEL expression is an independent poor prognostic factor in t(12;21)+ childhood ALL.|Multivariate analysis including age and WBC showed that only high AML1-TEL expression is an independent poor prognostic factor in t(12;21)+ childhood ALL.|The TEL-AML1 fusion product was expressed in all t(12;21)+ cases|The TEL-AML1 fusion product was expressed in all t(12;21)+ cases|The MEF (also known as ELF4) gene is repressed by several leukemia-associated fusion transcription factor proteins (PML-retinoic acid receptor alpha and AML1-ETO)|Reduced levels of TEL/AML1 expression were found in four of the six patients whose bone marrow or peripheral blood samples were obtained after treatment.|We observed that both GFI1 variants maintain the same activity as transcriptional repressors but differ in their regulation by the AML1/ETO (RUNX1/RUNX1T1) fusion protein produced in AML patients with a t(8;21) translocation.|RESULTS: The frequency of TEL/AML1 was 17.1% (21/123) in patients with precursor B-ALL.|Repression of RUNX1 by RUNX3 is required to allow the cell proliferation and this provides an experimental system to investigate the mechanism of the different activities of RUNX1 and RUNX3 in these cells.|RUNX3-mediated repression of RUNX1 in B cells.|siRNA inhibition of RUNX3 in lymphoblastoid cells resulted in increased RUNX1 expression|We show that RUNX3 regulates RUNX1 expression|RUNX3 repressed the RUNX1 P1 promoter by binding specifically to conserved RUNX sites near the transcription start of the promoter.|Knockdown of RUNX3 in these cells induces RUNX1 expression and inhibits cell proliferation|Epstein Barr virus immortalized human B lymphoblastoid cell lines express RUNX3|Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation.|The TLE binding VWRPY sequence from the C terminus of RUNX3 was found to be required for repression of the RUNX1 P1 promoter in a B-lymphoma cell line.|Cross-regulation of RUNX1 expression by RUNX3 plays a critical role in regulating proliferation of human B cells infected with Epstein-Barr virus (EBV).|The results demonstrate the importance of RUNX3-mediated repression of RUNX1 for EBV-driven B-cell proliferation and identify functional differences between human RUNX family proteins.|The TEL-RUNX1 fusion gene from acute B-lymphocytic leukemia retains almost all of the RUNX1 sequence but does not prevent B-cell proliferation in the same assay.|ETV6/RUNX1 fusion at diagnosis and relapse: some prognostic indications.|The prognostic significance of the profiles of these genes and the association between alterations in these genes and known cytogenetic prognostic factors (BCR/ABL; ETV6/RUNX1|The prognostic significance of the profiles of these genes and the association between alterations in these genes and known cytogenetic prognostic factors (BCR/ABL; ETV6/RUNX1|Manipulation of ETV6/RUNX1 expression and chromatin immunoprecipitation studies showed that the high expression of the miRNA cluster is an event independent of the ETV6/RUNX1 fusion protein.|Thus|ETV6/RUNX1 was found in 45% of cases and in the majority (10/18; 56%) of ALLs with sole +21.|Role of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemia.|Nine of the 34 patient samples expressed the ETV6/CBFA2 transcript.	FP|TP|TP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|NN|TP|TP|TP|TP|TP|FP|TP|TP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP	negative statement|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|incorrectly recognized gene name or identifier|incorrectly recognized gene name or identifier|incorrectly recognized gene name or identifier|incorrectly recognized gene name or identifier|general or irrelevant information|general or irrelevant information|incorrectly recognized gene name or identifier|general or irrelevant information|general or irrelevant information|incorrectly recognized gene name or identifier|general or irrelevant information|incorrectly recognized gene name or identifier|general or irrelevant information|incorrectly recognized gene name or identifier|general or irrelevant information|incorrectly recognized gene name or identifier|general or irrelevant information|general or irrelevant information|general or irrelevant information|incorrectly recognized gene name or identifier|incorrectly recognized gene name or identifier|incorrectly recognized gene name or identifier|incorrectly recognized gene name or identifier|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|potential direct influence on expression|general or irrelevant information|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|incorrectly recognized gene name or identifier|incorrectly recognized gene name or identifier|general or irrelevant information|incorrectly recognized gene name or identifier|general or irrelevant information|general or irrelevant information|general or irrelevant information|incorrectly recognized gene name or identifier	16832676|20339092|8609706|8639909|8657108|8751464|9359509|9652733|11001911|11078523|11801462|15749681|19813247|19837270|9031076|9118910|9359534|10488742|10910927|11559948|12220513|14527352|15024077|15356655|15837750|16581786|18635414|20075157|20197715|||||||||||||||||||19603429|15688019|16584381|19800266|19403666|15704129|19837270|16628190|16965388|19010836||||||||||8913730
MEF2C	KMT2A	Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C.	TP	binding to regulatory DNA-region/potential direct influence on expression	19584403
KLF6	JUN|SP2|KLF2	We also show that all KLF6 effects on c-Jun were largely dependent on phorbol ester (TPA/ionomycin) extracellular stimulation|However|ExoS was required for the enhanced expression of KLF2	NN|NN|FP	cooperation/competition in transcription|cooperation/competition in transcription|general or irrelevant information	15378003|17071613|16988269
TCF7L2	HOXB13|HOXB13|TCF7L2|GLI3|TCF7L2	In prostate cancers|TCF4 promoter analysis showed that HOXB13 does not regulate TCF4 at the transcriptional level.|However|PHS was shown to be caused by de novo heterozygous mutations of the TCF4 gene|It has been reported that beta-catenin promotes and p53 inhibits TCF-4 transcription	NN|FP|FP|FP|TP	cooperation/competition in transcription|negative statement|general or irrelevant information|incorrectly recognized gene name or identifier|binding to regulatory DNA-region/potential direct influence on expression	15928669|18627065|18781613||
ATF2	MSX2|JUN	This MSX2 repression function can be counteracted by overexpression of transcription factors CREB2 and RAP74.|Similarly	NN|FP	cooperation/competition in transcription|general or irrelevant information	15970589|10207054
FOXC1	PITX2|FOXC1|FOXO1|FOXC1|FOXF1	Ultimately|FOXC1 is required for cell viability and resistance to oxidative stress in the eye through the transcriptional regulation of FOXO1A.|Furthermore|FOXC1 regulates the expression of FOXO1A and binds to a conserved element in the FOXO1A promoter in vivo.|The expression profiles of FOXF1 and FOXF2 suggest a role in epithelial to mesenchymal transition	NN|TP|TP|TP|FP	cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information	16449236|17993506|19220249||
RUNX3	FOXO3|RUNX1|RUNX1|RUNX1|RUNX3|RUNX3|RUNX1|MYC|RUNX3|RUNX3|RUNX1|RUNX3|RUNX1|RUNX3|ETV6	The cooperation between RUNX3 and the PI3K/Akt signaling pathway component FoxO3a/FKHRL1 suggests the putative role of RUNX3 in the homoeostasis of gastric cells and in stomach cancer control.|Chromatin immunoprecipitation assays revealed that RUNX1 constitutively occupies the CD6 promoter in vivo|Chromatin immunoprecipitation assays revealed that RUNX1 constitutively occupies the CD6 promoter in vivo|Repression of RUNX1 by RUNX3 is required to allow the cell proliferation and this provides an experimental system to investigate the mechanism of the different activities of RUNX1 and RUNX3 in these cells.|RUNX3-mediated repression of RUNX1 in B cells.|Knockdown of RUNX3 in these cells induces RUNX1 expression and inhibits cell proliferation|Epstein Barr virus immortalized human B lymphoblastoid cell lines express RUNX3|c-Myc oncogene was found to be downregulated by BMP and/or RUNX3.|We show that upregulation of RUNX3 by BMP reduces c-Myc expression.|Evidence is presented suggesting that RUNX3 downregulates c-Myc expression by two parallel pathways-directly at the transcriptional level and through attenuation of beta-catenin/TCFs|Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation.|The TLE binding VWRPY sequence from the C terminus of RUNX3 was found to be required for repression of the RUNX1 P1 promoter in a B-lymphoma cell line.|Cross-regulation of RUNX1 expression by RUNX3 plays a critical role in regulating proliferation of human B cells infected with Epstein-Barr virus (EBV).|The results demonstrate the importance of RUNX3-mediated repression of RUNX1 for EBV-driven B-cell proliferation and identify functional differences between human RUNX family proteins.|The TEL-RUNX1 fusion gene from acute B-lymphocytic leukemia retains almost all of the RUNX1 sequence but does not prevent B-cell proliferation in the same assay.	NN|NN|FP|NN|TP|TP|FP|TP|TP|TP|TP|TP|FP|FP|FP	cooperation/competition in transcription|cooperation/competition in transcription|general or irrelevant information|cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression|general or irrelevant information|potential direct influence on expression|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information	16627973|19603429|16584381|20442291|19403666||||||||||
RUNX2	HES1|HES1|TWIST1|TWIST1|TWIST1|TWIST1|TWIST1|NFKB1|RUNX1|SNAI2|TWIST1|TWIST1|TWIST1|TWIST1	Furthermore|HES1 cooperates with pRb to activate RUNX2-dependent transcription.|This provides the first evidence that TWIST inactivation alters CBFA1/RUNX2 expression and Cbfa1 binding ability to the osteocalcin promoter|This provides the first evidence that TWIST inactivation alters CBFA1/RUNX2 expression and Cbfa1 binding ability to the osteocalcin promoter|TWIST inactivation reduces CBFA1/RUNX2 expression and DNA binding to the osteocalcin promoter in osteoblasts.|TWIST inactivation reduces CBFA1/RUNX2 expression and DNA binding to the osteocalcin promoter in osteoblasts.|We observed increased TWIST and RUNX2 expressions upon osteogenic induction and downregulation of TWIST through short hairpin RNA reduced the induction level of RUNX2.|The IKK2/NF-kappaB-induced BMP-2 up-regulation results in the enhancement of RUNX2 and Osterix expression|These results demonstrate a novel binding target for RUNX1 and RUNX2 proteins and suggest that Galectin-3 is regulated by RUNX1 and RUNX2 in human pituitary tumor cells by direct binding to the promoter region of LGALS3 and thus may contribute to pituitary tumor progression.|We found that SLUG is positively correlated with RUNX2 expression and deposition of mineralized matrix|This provides the first evidence that TWIST inactivation alters CBFA1/RUNX2 expression and Cbfa1 binding ability to the osteocalcin promoter|This provides the first evidence that TWIST inactivation alters CBFA1/RUNX2 expression and Cbfa1 binding ability to the osteocalcin promoter|TWIST inactivation reduces CBFA1/RUNX2 expression and DNA binding to the osteocalcin promoter in osteoblasts.|TWIST inactivation reduces CBFA1/RUNX2 expression and DNA binding to the osteocalcin promoter in osteoblasts.	NN|NN|TP|TP|TP|TP|TP|NN|FP|FP|TP|TP|TP|TP	cooperation/competition in transcription|cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|indirect interaction|general or irrelevant information|general or irrelevant information|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression	16753023|12270142|18453541|19414075|19020999|20128911|||||12270142|||
NKX3-1	SRF	The importance of these linear motifs in the transcriptional interaction of NKX3.1 and SRF was demonstrated by targeted mutagenesis of an NKX3.1 expression vector in a SMGA reporter assay.	NN	cooperation/competition in transcription	16814806
IRF2	IRF1|IRF1|IRF1|IRF1|IRF2|IRF1|IRF2|IRF2|IRF1	It appears that the tumour suppression function of IRF1 is abolished by IRF2.|IRF1 acts to repress IRF2 function through the repression of cyclin-dependent kinase (CDK) inhibitor p21WAF1 critical for cell growth control.|IRF1 functions as an activator for IFN and IFN-inducible genes|Alterations in IRF1/IRF2 expression in acute myelogenous leukemia.|Interferon regulatory factor-2 (IRF-2)|The transcriptional activator IFN regulatory factor 1 (IRF-1) and its antagonistic repressor IRF-2 are regulators of the IFN system.|IRF-1 also induced expression of its homologous repressor IRF-2 as indicated by EMSA analysis using an IRF-E probe from the IRF-2 promoter; and by cotransfection of IRF-1 together with an IRF-2 promoter CAT construct.|Therefore|Therefore	NN|FP|TP|FP|NN|TP|TP|TP|TP	cooperation/competition in transcription|general or irrelevant information|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|cooperation/competition in transcription|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	17073600.0|9204971|11559933||18395009|10321737|||
PRDM1	PRDM1|STAT3	BLIMP1 regulates cell growth through repression of p53 transcription.|Lastly	TP|FP	potential direct influence on expression|negative statement	18354204|
ETV1	JUN|JUN	In addition|Interestingly	NN|NN	cooperation/competition in transcription|cooperation/competition in transcription	17634427|
ID1	CYP27B1|ID1|BHLHE40	Notably|Interestingly|Taken together	NN|TP|TP	cooperation/competition in transcription|potential direct influence on expression|potential direct influence on expression	19098224|18556654|7828584
CYP27B1	NPPA|TCF7L2|WT1|PPARA|CYP27B1|PPARA|CYP27B1	These findings suggest that CDP is a novel differentiation stage-specific coactivator of the VDR in osteoblasts.|Furthermore|Nuclear run on experiments demonstrated that the effect of WT1 on VDR expression is at the transcriptional level.|After treatment with corresponding ligands|After treatment with corresponding ligands|In contrast|The strongest expression was found for the VDR	NN|TP|TP|FP|FP|FP|FP	cooperation/competition in transcription|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information	19888899|19924301|19667161||||
HMGB1	HMGB2	The involvement of HMGB1 and its close relative	NN	cooperation/competition in transcription	19223331
FOXO3	FOXO4|FOXO1|FOXO1	Altogether|Altogether|Using luciferase reporter assays and chromatin immunoprecipitations	NN|TP|TP	cooperation/competition in transcription|potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	19244250||
MAD1L1	MYC|MAD1L1	MAX dimerization protein 1 (MAD1) is a transcription suppressor that antagonizes MYC-mediated transcription activation|MAX dimerization protein 1 (MAD1) is a transcription suppressor that antagonizes MYC-mediated transcription activation	NN|NN	cooperation/competition in transcription|cooperation/competition in transcription	19526459|
KLF12	FOSB	Two transcription factors	NN	cooperation/competition in transcription	19745787
NKX2-5	GATA4|GATA4|NKX2-5|GATA4|GATA4|NKX2-5|GATA6	Using promoter-luciferase reporter assay combined with mutational analysis of the NKEs we demonstrated that the identified NKX2-5 binding sites were essential for the suppression of beta-catenin|Here|NKX2-5 regulates the expression of beta-catenin and GATA4 in ventricular myocytes.|Using promoter-luciferase reporter assay combined with mutational analysis of the NKEs we demonstrated that the identified NKX2-5 binding sites were essential for the suppression of beta-catenin|Here|NKX2-5 regulates the expression of beta-catenin and GATA4 in ventricular myocytes.|In particular	TP|FP|FP|TP|FP|FP|FP	binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information	19479054|16607277|||||
GATA4	GATA4|GATA4|NKX2-5|GATA4|GATA4|NKX2-5|GATA6	Using promoter-luciferase reporter assay combined with mutational analysis of the NKEs we demonstrated that the identified NKX2-5 binding sites were essential for the suppression of beta-catenin|Here|NKX2-5 regulates the expression of beta-catenin and GATA4 in ventricular myocytes.|Using promoter-luciferase reporter assay combined with mutational analysis of the NKEs we demonstrated that the identified NKX2-5 binding sites were essential for the suppression of beta-catenin|Here|NKX2-5 regulates the expression of beta-catenin and GATA4 in ventricular myocytes.|In particular	TP|FP|FP|TP|FP|FP|FP	binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information	19479054|16607277|||||
POU5F1	RARA	Specifically	TP	potential direct influence on expression	8152920
FOXA2	FOXA2|HNF4A	The results of our study suggest that mutations in HNF3B are not a common cause of MODY in Japanese subjects|We have tested this hypothesis by screening a panel of 57 unrelated Japanese subjects with a clinical diagnosis of MODY for mutations in HNF3B.	FP|FP	general or irrelevant information|general or irrelevant information	|
RFX1	RFX1|MYCN	These findings suggest that nuclear translocation and binding of RFX1 to the X box cause the down-regulation of myc expression|The N-myc gene	TP|FP	potential direct influence on expression|general or irrelevant information	10918054|
KLF2	KLF2|MYC|KLF2	Forced expression of LKLF was associated with markedly decreased c-Myc expression.|Forced expression of LKLF was associated with markedly decreased c-Myc expression.|In addition	TP|TP|TP	potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	11477405||
NEUROD1	NEUROD1|NEUROD2|NEUROD2	Inhibition of BETA2/NeuroD by Id2.|In these assays|NEUROD1 acts in vitro as an upstream regulator of NEUROD2 in trophoblast cells.	TP|TP|TP	potential direct influence on expression|potential direct influence on expression|potential direct influence on expression	12526101|14732494|
PAX6	PAX2|CTCF	Four of the detected mutations affected PAX6-mediated transcriptional repression of the PAX2 promoter in a reporter assay.|CONCLUSIONS: These findings indicate that CTCF regulates PAX6 expression in response to stress-induced conditions and that the molecular base of CTCF controlling PAX6 expression is through five functional and specific motifs in the region upstream from the PAX6 P0 promoter in corneal epithelial cells	TP|TP	potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	12721955|16723452
MNX1	E2F3|ETV6|MNX1	Downstream analysis of PI3K revealed that E2F3 may mediate activation of HLXB9.|MNX1-ETV6 fusion gene in an acute megakaryoblastic leukemia and expression of the MNX1 gene in leukemia and normal B cell lines.|MNX1-ETV6 fusion transcripts (previously HLXB9-ETV6) were rarely detected in AML patients having t(7;12)(q36;p13).	TP|FP|FP	potential direct influence on expression|general or irrelevant information|general or irrelevant information	15772702|18940475|
CDX2	TTF1	RESULTS: Organ-specific immunostaining profiles using multiple markers provided high sensitivity	FP	general or irrelevant information	17922593
BCL3	MYC|MYC	Cloning and sequence analysis of the rearranged MYC gene revealed that MYC was truncated at the Pvu II site at the end of the first exon of MYC and had joined into the regulatory elements of a gene that we called BCL3 (B-cell leukemia/lymphoma 3).|Cloning and sequence analysis of the rearranged MYC gene revealed that MYC was truncated at the Pvu II site at the end of the first exon of MYC and had joined into the regulatory elements of a gene that we called BCL3 (B-cell leukemia/lymphoma 3).	FP|FP	general or irrelevant information|general or irrelevant information	2682663|
GFI1	GFI1|ETS1	Luciferase (Luc) assays using artificial reporters showed that GFI1 repressed ETS1-mediated transcriptional activation and ETS1 repressed GFI1-mediated transcriptional activation|Luciferase (Luc) assays using artificial reporters showed that GFI1 repressed ETS1-mediated transcriptional activation and ETS1 repressed GFI1-mediated transcriptional activation	TP|TP	potential direct influence on expression|potential direct influence on expression	17213822|
E2F2	FOSB	AP-1 blockade also led to reduced expression of E2F1 and E2F2	TP	potential direct influence on expression	17637753
MECOM	MECOM	A hematologic complete remission was accompanied by a reduction of MDS1-EVI1/ EVI1 expression levels of at least 2 log while persistent leukemia was reflected by an MDS1-EVI1/ EVI1 expression in the range of the primary diagnostic sample.	TP	potential direct influence on expression	17693194
NR4A1	MEF2C|MEF2C|MEF2C|MEF2C|NR4A2	MEF2C consistently inhibits expression of NR4A1/NUR77|MEF2C consistently inhibits expression of NR4A1/NUR77|MEF2C consistently inhibits expression of NR4A1/NUR77|MEF2C consistently inhibits expression of NR4A1/NUR77|KN93 partially inhibited the effect of Ang II on NURR1 mRNA levels but did not modify the effect on expression of NGFIB.	TP|TP|TP|TP|FP	potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|potential direct influence on expression|negative statement	18079734||18079734||14645496
NANOG	KLF4	KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells.	TP	potential direct influence on expression	19522013
ZNF148	SOX18	In this paper	TP	potential direct influence on expression	18496767
BHLHE40	ID1|BHLHE40	Interestingly|Taken together	TP|TP	potential direct influence on expression|potential direct influence on expression	18556654|
ETV4	E2F1|E2F1|ETV4|FOSB	DNA damage by etoposide causes E2F1-dependent induction of E1AF expression at transcriptional level.|Here|Furthermore|Finally	TP|TP|FP|FP	potential direct influence on expression|potential direct influence on expression|general or irrelevant information|general or irrelevant information	18687701|||15754128
SOX9	CDX2|HES1|HES1|HES1|SRY|RARA|SRY|NR5A1|GATA4	In the intestine|Here we show that retinoic acid induces HES-1 expression via upregulation of transcription factor SOX9.|In reporter assays|SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells.|However|RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition.|They include the SRY-related gene|Basal expression of AMH is induced by SOX9; GATA4|Basal expression of AMH is induced by SOX9; GATA4	TP|TP|TP|TP|FP|FP|FP|FP|FP	potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information	19795349|19322650|11990793|12420222|15135034|15383177|||
GATA2	MECOM|MECOM|MECOM|MECOM	EVI1 is a member of a group of transcription factors with C-terminal binding protein (CtBP)-binding motifs that act as transcriptional co-repressors; however|Acetylation at Lys(564)|Acetylation of lysine 564 adjacent to the C-terminal binding protein-binding motif in EVI1 is crucial for transcriptional activation of GATA2.|Mutation of Lys(564) to alanine (K564A) markedly reduced the ability of EVI1 to bind DNA and activate transcription of GATA2.	TP|FP|FP|FP	potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information	20363750|||
GATA3	FOXA1|FOXA1|FOXA1	FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis.|These data reveal that FOXA1 is necessary for hormonal responsiveness in the developing mammary gland and ERalpha-positive breast cancers|Using breast cancer cell lines	TP|TP|TP	potential direct influence on expression|potential direct influence on expression|potential direct influence on expression	20501593||
AIRE	FOSB|AIRE|AIRE|AIRE	Interestingly|Because we recently found functional HSEs in the human and rodent c-fos promoters|In this study|Because the stress response can also be induced by nonthermal stimuli	FP|FP|FP|FP	negative statement|general or irrelevant information|general or irrelevant information|general or irrelevant information	11026560.0|9761780|8049495|
MXI1	MXI1	The MXI1 gene	TP	binding to regulatory DNA-region/potential direct influence on expression	17482131
CUX1	MYC	The human Cut-like homeobox gene	TP	binding to regulatory DNA-region/potential direct influence on expression	9178912.0
TBX1	TBX1|TBX1|GSC2|GSC2|GSC2|GSC2|TBX1|TBX1|GSC2|GSC2|GSC2|GSC2	Thus|Thus|Due to its location in the critical region on 22q11|Due to its location in the critical region on 22q11|Due to its location in the critical region on 22q11|Due to its location in the critical region on 22q11|Thus|Thus|Due to its location in the critical region on 22q11|Due to its location in the critical region on 22q11|Due to its location in the critical region on 22q11|Due to its location in the critical region on 22q11	TP|TP|FP|FP|FP|FP|TP|TP|FP|FP|FP|FP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information	9811926|9441739|||||9811926|9441739||||
FOXD3	FOXM1	A novel repressor of the Winged Helix (formerly HNF-3/Forkhead) transcriptional regulatory family	TP	binding to regulatory DNA-region/potential direct influence on expression	10460485
PSORS1C2	PSORS1C2|FOSB|FOSB	AP-1 is the cis element mediating the transcriptional activation of SPR1 by PMA|AP-1 is the cis element mediating the transcriptional activation of SPR1 by PMA|Mutation of the AP-1 site abolishes the induction of SPR1 expression by PMA.	TP|TP|TP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	10501656||
CASR	NR1I2|CASR	As the transcriptional activity of PXR and CAR is not affected by IL-6 in cell-based reporter assays|As the transcriptional activity of PXR and CAR is not affected by IL-6 in cell-based reporter assays	TP|TP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	10924340|
TAF1	JUN|TBP|JUN|TBP|JUN|JUN|TAF1|TBP|TAF1|TBP|TAF1	In support of this hypothesis|In support of this hypothesis|Moreover|Moreover|We hypothesized that c-Jun is capable of derepressing the effect of the TAF(II)250 N terminus on TFIID-driven transcription.|We hypothesized that c-Jun is capable of derepressing the effect of the TAF(II)250 N terminus on TFIID-driven transcription.|We hypothesized that c-Jun is capable of derepressing the effect of the TAF(II)250 N terminus on TFIID-driven transcription.|TAF(II)250 is a scaffold for assembly of other TAF(II)s and TBP into TFIID|TAF(II)250 is a scaffold for assembly of other TAF(II)s and TBP into TFIID|The p250 subunit of native TATA box-binding factor TFIID is the cell-cycle regulatory protein CCG1.|We found that TAF1 induces G1 progression in a p53-dependent manner.	TP|TP|TP|TP|FP|FP|FP|TP|FP|FP|FP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information|binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information|general or irrelevant information	11316804|11686293||||||||8450888|
NR1H2	SREBF1|NR1H3|NR1H2	The nuclear receptors liver X receptor alpha (LXRalpha) (NR1H3) and LXRbeta (NR1H2) are important regulators of genes involved in lipid metabolism|The nuclear receptors liver X receptor alpha (LXRalpha) (NR1H3) and LXRbeta (NR1H2) are important regulators of genes involved in lipid metabolism|The nuclear receptors liver X receptor alpha (LXRalpha) (NR1H3) and LXRbeta (NR1H2) are important regulators of genes involved in lipid metabolism	TP|FP|FP	binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information	11504730||
SREBF1	SREBF1|NR1H3|NR1H2	The nuclear receptors liver X receptor alpha (LXRalpha) (NR1H3) and LXRbeta (NR1H2) are important regulators of genes involved in lipid metabolism|The nuclear receptors liver X receptor alpha (LXRalpha) (NR1H3) and LXRbeta (NR1H2) are important regulators of genes involved in lipid metabolism|The nuclear receptors liver X receptor alpha (LXRalpha) (NR1H3) and LXRbeta (NR1H2) are important regulators of genes involved in lipid metabolism	TP|FP|FP	binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information|general or irrelevant information	11504730||
HOXB13	TCF7L2|TCF7L2	This study suggests that HOXB13|Western blot analysis demonstrated that HOXB13 down-regulates the expression of TCF-4 and its responsive genes	TP|TP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	15126340|
KMT2A	HOXA9|MEIS1|HOXA9|HOXC13	These results suggest that MLL aberrations may regulate MEIS1 and HOXA9 gene expression in ALL-derived cell lines|These results suggest that MLL aberrations may regulate MEIS1 and HOXA9 gene expression in ALL-derived cell lines|Gene expression analyses demonstrate a distinct profile for MLL-rearranged leukemias with consistent high-level expression of select Homeobox genes|Overall	TP|TP|TP|TP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	15160920|17671196||19922474
PLAGL1	PPARG	We show that in human colon carcinoma cells	TP	binding to regulatory DNA-region/potential direct influence on expression	17178896
NFATC2	FOXP3|NFATC2|FOXP3|NFATC1	By NFAT1 knockdown in CD4(+)CD25(+) T cells|Our findings indicate that decreased NFAT1 could explain low FOXP3 expression and diminished Treg frequency in aplastic anemia.|Transfection of FOXP3-deficient CD4(+)CD25(+) T cells from patients with a plasmid encoding wild-type NFAT1 resulted in increased FOXP3 expression in these cells.|We demonstrate that transcription from the NFAT2 promoter is significantly suppressed by FOXP3	TP|TP|TP|TP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	17463169|17617603|19564342|
FOXP3	FOXP3|NFATC2|FOXP3|NFATC1	By NFAT1 knockdown in CD4(+)CD25(+) T cells|Our findings indicate that decreased NFAT1 could explain low FOXP3 expression and diminished Treg frequency in aplastic anemia.|Transfection of FOXP3-deficient CD4(+)CD25(+) T cells from patients with a plasmid encoding wild-type NFAT1 resulted in increased FOXP3 expression in these cells.|We demonstrate that transcription from the NFAT2 promoter is significantly suppressed by FOXP3	TP|TP|TP|TP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	17463169|17617603|19564342|
HOXA1	STAT3	The protein levels of STAT3 and 5B	TP	binding to regulatory DNA-region/potential direct influence on expression	18276758
RNASEH2A	FOSB|FOSB	These findings suggest that deregulation of AP-1 expression in CTCL is the result of aberrant expression of JUNB and possible JUND resulting from genomic amplification and constitutive activation of ERK1/2 MAPK in this type of lymphoma.|These findings suggest that deregulation of AP-1 expression in CTCL is the result of aberrant expression of JUNB and possible JUND resulting from genomic amplification and constitutive activation of ERK1/2 MAPK in this type of lymphoma.	TP|TP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	18494816|
JUND	FOSB|FOSB	These findings suggest that deregulation of AP-1 expression in CTCL is the result of aberrant expression of JUNB and possible JUND resulting from genomic amplification and constitutive activation of ERK1/2 MAPK in this type of lymphoma.|These findings suggest that deregulation of AP-1 expression in CTCL is the result of aberrant expression of JUNB and possible JUND resulting from genomic amplification and constitutive activation of ERK1/2 MAPK in this type of lymphoma.	TP|TP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	18494816|
NR4A3	NR4A3|PPARG	The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene.|Western blot or immunohistochemical analyses confirm that PPARG and NDRG2 are expressed in tumours positive for EWSR1/NR4A3.	TP|TP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	18855877|
MEIS1	KMT2A	These results show that MEIS1 expression is important for MLL-rearranged leukemias and suggest that MEIS1 promotes cell-cycle entry.	TP	binding to regulatory DNA-region/potential direct influence on expression	19109563
TBX2	TBX2	In carcinogenesis	TP	binding to regulatory DNA-region/potential direct influence on expression	
DLX5	MYC|TP63	Here we demonstrate by luciferase assay that the MYC promoter is specifically activated by overexpression of DLX5 and that two DLX5 binding sites in the MYC promoter are important for transcriptional activation of MYC.|We show that p63 binds to an enhancer element in the SHFM1 locus on chromosome 7q and that this element controls expression of DLX6 and possibly DLX5	TP|TP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	19497851|20808887
PTPN6	PTPN6|PTPN6	Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.|This study investigates the functional relationship between trkA	TP|TP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	19749791|
ID3	POU5F1|ID1	POU5F1 expression positively correlated with ID1 and ID3 expression (P < 0.05) but not with NANOG or SOX2 expression.|BMP-6 also induced phosphorylation of Smad1/5/8	TP|FP	binding to regulatory DNA-region/potential direct influence on expression|general or irrelevant information	19815608|17899540
HMGA2	ZNF350|HMGA2|HMGA2|HMGA2	Here|Here|These results suggest that activation of HMGA2 gene expression through derepression of the ZBRK1/BRCA1/CtIP complex is a significant step in accelerating breast tumorigenesis|Using microarray analysis	TP|TP|TP|TP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	20007691|||
ZNF350	ZNF350|HMGA2|HMGA2|HMGA2	Here|Here|These results suggest that activation of HMGA2 gene expression through derepression of the ZBRK1/BRCA1/CtIP complex is a significant step in accelerating breast tumorigenesis|Using microarray analysis	TP|TP|TP|TP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	20007691|||
MEF2A	ATF6	Finally	TP	binding to regulatory DNA-region/potential direct influence on expression	20165829
IRF8	IRF8|IRF8|WT1|WT1	A reporter construct with the IRF8 promoter was repressed by WT1|In this study|Interestingly|Upon overexpression in CD34+ progenitors	TP|TP|TP|TP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	20237505|||
NFE2	NFE2|RUNX1	Our data identify NF-E2 as a novel AML1 target gene and delineate a role for aberrant AML1 expression in mediating elevated NF-E2 expression in MPN patients|RNAi-mediated suppression of either AML1 or of its binding partner CBF-beta significantly decreased NF-E2 expression.	TP|TP	binding to regulatory DNA-region/potential direct influence on expression|binding to regulatory DNA-region/potential direct influence on expression	20339092|
MSC	KLF4	In addition	TP	binding to regulatory DNA-region/potential direct influence on expression	20519630
TLX1	MYC	CONCLUSIONS: We found that TLX1 and NOTCH synergistically regulate transcription in T-ALL	TP	binding to regulatory DNA-region/potential direct influence on expression	20618946
ETV6	ETV6|RUNX1|ETV6|ETV6|RUNX1|ETV6|RUNX1|ETV6|RUNX1|ETV6|ETV6|RUNX1|ETV6|RUNX1|RUNX1|RUNX1|RUNX1|ETV6|RUNX1|RUNX1|RUNX1|ETV6|RUNX1|KMT2A|RUNX1|KMT2A|TCF3|ETV6|MNX1	In addition|The reciprocal AML1/TEL transcripts were detected in 12 (86%) of the 14 cases expressing a TEL/AML1 transcript.|The reciprocal AML1/TEL transcripts were detected in 12 (86%) of the 14 cases expressing a TEL/AML1 transcript.|Lack of TEL/AML1 fusion in pediatric AML: further evidence for lineage specificity of TEL/AML1.|Lack of TEL/AML1 fusion in pediatric AML: further evidence for lineage specificity of TEL/AML1.|We also show that the leukemia-associated fusion protein TEL/AML1 is modified by SUMO-1 and found in the TEL bodies|We also show that the leukemia-associated fusion protein TEL/AML1 is modified by SUMO-1 and found in the TEL bodies|TEL-AML1 expression was normalized relative to the levels of AML1 transcripts.|DESIGN AND METHODS: The quantitative estimation of TEL-AML1 transcripts was performed in 10 P-ALL TEL-AML1-positive patients.|DESIGN AND METHODS: The quantitative estimation of TEL-AML1 transcripts was performed in 10 P-ALL TEL-AML1-positive patients.|The within-assay coefficient of variation (CV) for TEL-AML1 was 7.0% and the between-assay CV was 13%.|The crucial chimeric gene|The crucial chimeric gene|AML1 was found to be expressed but no normal TEL proteins were detected.|In t(12;21) samples|Although AML1B (and a shorter AML1 isoform|The 12;21 chromosomal translocation occurs in leukemic cells from 20(30% of patients with B-lineage childhood acute lymphoblastic leukemia|The 12;21 chromosomal translocation occurs in leukemic cells from 20(30% of patients with B-lineage childhood acute lymphoblastic leukemia|CONCLUSION: High AML1-TEL expression is an independent poor prognostic factor in t(12;21)+ childhood ALL.|Multivariate analysis including age and WBC showed that only high AML1-TEL expression is an independent poor prognostic factor in t(12;21)+ childhood ALL.|The TEL-AML1 fusion product was expressed in all t(12;21)+ cases|The TEL-AML1 fusion product was expressed in all t(12;21)+ cases|Moreover|For the ALL|Moreover|In AML|Our aim is to develop a highly sensitive and specific method to screen simultaneously for the four most frequent fusion transcripts resulting from specific chromosomal translocations|MNX1-ETV6 fusion gene in an acute megakaryoblastic leukemia and expression of the MNX1 gene in leukemia and normal B cell lines.|MNX1-ETV6 fusion transcripts (previously HLXB9-ETV6) were rarely detected in AML patients having t(7;12)(q36;p13).	FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP|FP	incorrectly recognized gene name or identifier|general or irrelevant information|general or irrelevant information|incorrectly recognized gene name or identifier|general or irrelevant information|incorrectly recognized gene name or identifier|general or irrelevant information|incorrectly recognized gene name or identifier|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information|general or irrelevant information	8751464|9652733|11078523|11801462|9031076|9671410|10023677|10488742|15837750|16038737|19579075||||||||||||||8653712|11165321|15024455|18940475|
GRHL3	SOX10	On the other hand	FP	incorrectly recognized gene name or identifier	16735048
GSC	GSC	Only two carcinomas (1 IPGC and 1 GSC) harboring a p53 mutation did not show any p53 expression.	FP	incorrectly recognized gene name or identifier	17523278
ID4	E2F1	The protein complex mutant p53-E2F1 assembles on specific regions of the ID4 promoter and positively controls ID4 expression.	FP	incorrectly recognized gene name or identifier	19783986
NFIB	NFIB|MYB	Our data indicate that the MYB-NFIB fusion is a hallmark of ACC and that deregulation of the expression of MYB and its target genes is a key oncogenic event in the pathogenesis of ACC.|Our findings also suggest that the gain-of-function activity resulting from the MYB-NFIB fusion is a candidate therapeutic target.	FP|FP	incorrectly recognized gene name or identifier|incorrectly recognized gene name or identifier	19841262|
HLF	TCF3|TCF3|TCF3	Wild-type and chimeric HLF proteins also bound closely related sites identified previously for bZIP proteins of both the proline- and acidic amino acid-rich (PAR) and C/EBP subfamilies; however|RT-PCR was used to detect the E2A-HLF transcript.|The fusion E2A-HLF was amplified by RT-PCR and sequenced	FP|FP|FP	general or irrelevant information|general or irrelevant information|general or irrelevant information	8065331|12111652|
SMAD4	SMAD2|SMAD2|SMAD2	The gene for MADR2 was found to reside on chromosome 18q21|These results suggest that functional abrogation of SMAD2 or SMAD3 and increased expression of SMAD6 or SMAD7 are infrequent in pancreatic carcinomas and further stress the particular importance of SMAD4 inactivation in pancreatic carcinogenesis|These results suggest that functional abrogation of SMAD2 or SMAD3 and increased expression of SMAD6 or SMAD7 are infrequent in pancreatic carcinomas and further stress the particular importance of SMAD4 inactivation in pancreatic carcinogenesis	FP|FP|FP	general or irrelevant information|general or irrelevant information|general or irrelevant information	8752209|9892110|
PAX7	FOXO1	Chromatin release studies suggested that the amplified sequences correlated with amplification of the PAX7-FKHR fusion gene which resulted from the insertion of PAX7 sequences into the first intron of FKHR gene	FP	general or irrelevant information	8889501
NFYC	NFYA|NFYB	None of the CBF-A and CBF-C subunits|The NF-YB/NF-YC structure gives insight into DNA binding and transcription regulation by CCAAT factor NF-Y.	FP|FP	general or irrelevant information|general or irrelevant information	9813075|12401788
SMAD7	SMAD2|SMAD2	These results suggest that functional abrogation of SMAD2 or SMAD3 and increased expression of SMAD6 or SMAD7 are infrequent in pancreatic carcinomas and further stress the particular importance of SMAD4 inactivation in pancreatic carcinogenesis|These results suggest that functional abrogation of SMAD2 or SMAD3 and increased expression of SMAD6 or SMAD7 are infrequent in pancreatic carcinomas and further stress the particular importance of SMAD4 inactivation in pancreatic carcinogenesis	FP|FP	general or irrelevant information|general or irrelevant information	9892110|
NR2F1	LGALS12	Finally	FP	general or irrelevant information	10652338
ERF	FLI1|FLI1	In this study|The FLI1/ERF repressor	FP|FP	general or irrelevant information|general or irrelevant information	10975680.0|
SMAD2	SMAD4	None of the tumors showed mutations of MADH2 and MADH4 or loss of detectable transcripts from MADH2	FP	general or irrelevant information	11304690
FOXE3	PAX6	In a small cohort (n = 13) of patients with Peters' anomaly	FP	general or irrelevant information	11980846
SREBF2	ATF6	ATF6 modulates SREBP2-mediated lipogenesis.	FP	general or irrelevant information	14765107
CREM	JUN	This article will review the defective transcription regulation of IL-2 in SLE T cells	FP	general or irrelevant information	15204092
ATF1	MITF	Knockdown/rescue studies revealed that MITF mediates the requirement of EWS-ATF1 for CCS survival in vitro and in vivo as well as for melanocytic differentiation.	FP	general or irrelevant information	16766266
DBP	TEF|NFIL3	Furthermore|CONCLUSIONS: Results from this study suggest that DBP and E4BP4 might consist of a reciprocating mechanism in which DBP activates the transcription of the CYP3A4 gene during the time of day when DBP is abundant	FP|FP	general or irrelevant information|general or irrelevant information	17057225|18004209
HEYL	HEY2|HEYL	Burk (RB) discriminant function of the HRT2 and 83.3% for the FSM discriminant function of the HRT3.|CONCLUSIONS: At 95% fixed specificity	FP|FP	general or irrelevant information|general or irrelevant information	18078851|
HEY2	HEY2|HEYL	Burk (RB) discriminant function of the HRT2 and 83.3% for the FSM discriminant function of the HRT3.|CONCLUSIONS: At 95% fixed specificity	FP|FP	general or irrelevant information|general or irrelevant information	18078851|
SIM2	AIRE	The ability of PIAS1 to localize into NBs and interconnect with AIRE is neither dependent on the SP-RING domain nor the SIM.	FP	general or irrelevant information	18083234
ISL1	TUBB4B	mRNA expression for NeuroD/Beta2	FP	general or irrelevant information	18374087
STAT5A	PPARG|PPARG	Further|Further	FP|FP	general or irrelevant information|general or irrelevant information	18431514|
STAT5B	PPARG|PPARG	Further|Further	FP|FP	general or irrelevant information|general or irrelevant information	18431514|
TBX3	TBX5	We speculate that the gain-of-function mechanism underlies the mild skeletal phenotype and paroxysmal atrial fibrillation and suggest a possible role of TBX5 in the development of (paroxysmal) atrial fibrillation based on a gain-of-function either through a direct stimulation of target genes via TBX5 or indirectly via TBX5 stimulated TBX3.	FP	general or irrelevant information	18451335
FOXP1	FOXP2	Expression of FOXP2 in the developing monkey forebrain: comparison with the expression of the genes FOXP1	FP	general or irrelevant information	18461604
ERG	WT1	In multivariable analyses	FP	general or irrelevant information	18559874
SOX2	TP63	p63 was expressed in 96% of esophageal squamous cell carcinomas and 100% of anal canal squamous cell carcinomas; the single squamous cell carcinoma negative for p63 was strongly positive for SOX2.	FP	general or irrelevant information	19716157
